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Abstract:  Prenatal cocaine (PC) exposure negatively impacts the developing nervous system, including numerous 
changes in serotonergic signaling. Cocaine, a competitive antagonist of the serotonin transporter, similar to selective sero-
tonin reuptake inhibitors (SSRIs), also blocks dopamine and norepinephrine transporters, leaving the direct mechanism 
through which cocaine disrupts the developing serotonin system unclear. In order to understand the role of the serotonin 
transporter in cocaine’s effect on the serotonergic system, we compare reports concerning PC and prenatal antidepressant 
exposure and conclude that PC exposure affects many facets of serotonergic signaling (serotonin levels, receptors, trans-
porters) and that these effects differ significantly from what is observed following prenatal SSRI exposure. Alterations in 
serotonergic signaling are dependent on timing of exposure, test regimens, and sex. Following PC exposure, behavioral 
disturbances are observed in attention, emotional behavior and stress response, aggression, social behavior, communication, 
and like changes in serotonergic signaling, these effects depend on sex, age and developmental exposure. Vulnerability  
to the effects of PC exposure can be mediated by several factors, including allelic variance in serotonergic signaling 
genes, being male (although fewer studies have investigated female offspring), and experiencing the adverse early   
environments that are commonly coincident with maternal drug use. Early environmental stress results in disruptions in 
serotonergic signaling analogous to those observed with PC exposure and these may interact to produce greater behavioral 
effects observed in children of drug-abusing mothers. We conclude that based on past evidence, future studies should put 
a greater emphasis on including females and monitoring environmental factors when studying the impact of PC exposure.  
Keywords: Aggression, depression, development, early environmental stress, prenatal cocaine, prenatal antidepressants,   
serotonin, sex differences.  
A. INTRODUCTION 
1. Prenatal Cocaine Exposure Remains a Public Health 
Concern 
  Perception about the impact of prenatal cocaine (PC) 
exposure on infants and children has evolved since the first 
studies were performed 30 years ago [1,2]. Initially, there 
was great concern about “crack babies” and during the mid 
to late 1980s, the media widely reported major teratological 
effects, including malformations and withdrawal symptoms 
[3-6]. Although early case reports showed instances of se-
vere physical teratological abnormalities [7,8], the majority 
of PC exposed infants exhibited no diagnosable health prob-
lems. Developmental studies began to suggest that such se-
vere effects were not as common as once expected, and as 
the children matured, behavioral effects became less pro-
nounced [9]. However, it is now clear that PC exposure 
causes reliable and long-lasting behavioral effects, which, 
although small in magnitude, are still significant [9,10]. In 
the 1990s, more than 45,000 women reported cocaine use 
during some period of their pregnancy [11], and gestational 
cocaine use has continued in the United States, with   
approximately 5% of pregnant women reporting illicit   
substance use in 2006 [12]. It has been suggested that PC 
exposure increases the number of children who need special  
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educational services by as many as 80,550 per year, costing 
billions in educational and medical services [9,13]. These 
data highlight the importance of understanding the neurobe-
havioral outcomes of PC exposure in the hope of developing 
pharmacological or behavioral therapies for affected chil-
dren. PC exposure has been extensively studied, providing 
evidence of disruptions in cardiac, respiratory, renal and neu-
rological functions [14-17], including effects on a number   
of specific neurobiological systems [18-21]. However,   
this review will primarily focus on what is known about   
the effects of PC exposure on the development of the   
serotonergic system, given that cocaine can act directly on 
this signaling system.  
2. Prenatal Exposure to SSRIs is Widespread Although 
the Long-term Effects are Unclear 
  Selective serotonin reuptake inhibitors (SSRIs) like   
fluoxetine, sertraline and paroxetine act as potent anti- 
depressants by elevating intrasynaptic levels of serotonin (5-  
HT) through blocking the ability of the serotonin transporter  
(SERT) to transport 5-HT into the presynaptic nerve terminal  
[22]. SSRIs have a greater affinity for SERT, and lower   
affinities for dopamine (DA) and norepinephrine (NE) trans- 
porters compared to cocaine (see Table 1) [23]. Although   
a large number of pregnant women use SSRIs to control   
symptoms of depression and anxiety, little is known about  
how these drugs may affect the development of the fetal   
nervous system. Similar to PC exposure, the majority of   
animal studies have shown no gross teratological effects of  Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors  Current Neuropharmacology, 2011, Vol. 9, No. 3    479 
prenatal SSRI exposure, although a few studies have   
reported lower birth weight and/or delayed motor develop- 
ment [24-28]. The safety of human gestational use of   
these drugs has recently been reviewed and potential risks  
of major malformations, (e.g., persistent pulmonary hypoten- 
sion, cardiac defects, miscarriage/spontaneous abortion) 
from certain SSRIs noted [29-31]. Recently, preclinical   
studies have begun reporting long-lasting molecular,   
physiologic and behavioral changes in offspring prenatally   
exposed to SSRIs [32]. In addition, subtle behavioral   
changes similar to those observed in PC exposure [9]   
have been observed in infants prenatally exposed to SSRIs  
[33], but there have not yet been detailed studies at later   
ages. 
3. Changes in Serotonergic Signaling May Underlie   
Behavioral Changes 
  Serotonin is primarily produced by the raphe nuclei in the 
hindbrain with efferent projections throughout the central 
nervous system (CNS), mediating and modulating a number 
of behaviors [34]. The many mechanisms of 5-HT release, 
auto-regulation, reuptake as well as the many 5-HT receptor 
subtypes, illustrate the complexity of the serotonergic signal-
ing system, and the diverse ways that cocaine and SSRIs 
may impact this signaling (Fig. 1). Nonetheless, it is clear 
from the available literature that PC exposure has multiple 
effects on the developing 5-HT system, the extent of which 
are dependent on sex, age, dose and gestational exposure 
period, as well as the early postnatal environment. Given the 
important and dynamic roles of 5-HT in brain development, 
including autoregulation of its own neuronal development 
[35], and the complex interactions between receptors and 
transporters [37-39], it might seem reasonable to attribute 
differences in serotonergic signaling following PC exposure 
solely to blockade of SERT. However, the effects of PC ex-
posure on dopamine (DA) and norepinephrine (NE) trans-
porters must also be considered, especially in terms of inter-
ference with the actions of stress hormones and promotion of 
fetal vasoconstriction [39,40]. To address the role of SERT 
blockade in the serotonergic and behavioral impact of PC 
exposure, we compare current PC exposure data and effects 
of prenatal exposure to antidepressants, specifically SSRIs, 
to provide insights into possible common mechanisms un-
derlying the detrimental effects of PC exposure, and poten-
tial therapeutic strategies.  
4. Organization of This Review 
  Throughout this review, we present data from the avail-
able literature on the effects of PC exposure followed by the 
effects of prenatal antidepressant exposure. First, we address 
effects on the developing serotonergic system. Serotonin is a 
phylogenetically old signaling molecule with 14 different 
cognate receptor subtypes, many of which come in a variety 
of alleles [41-44]. Given the variety of 5-HT receptors, the 
study of PC exposure has focused mainly on receptors impli-
cated in physiologic or behavioral problems observed in pre-
natally exposed offspring, namely 5–HT1A, 5-HT2A, and 5-
HT3 receptors, which, exhibit very different responses to PC 
exposure. 
Table 1.  Kd Values for Each Drug for Human Serotonin Transporter (SERT), Norepinephrine Transporter (NET) and Dopamine 
Transporter (DAT) 
Drug Kd for SERT  Kd for NET  Kd for DAT 
Cocaine 340  1420  220 
Amnefolic Acid   >10,000  >10,000  18.7* 
Amitriptyline 4.30  35  3250 
Bupropion 9100  52000  520 
Citalopram 1.16  4070  28100 
Fluoxetine 0.81  240  3600 
Fluovoxamine 2.2  1300  9200 
Imipramine 1.4  37  8500 
Iprindole 1620  1262  6530 
Mianserin 4000  71  1000 
Nomifensine 1010  15.6  56 
Norfluoxetine 1.47  1426  420 
Paroxetine 0.13  40  490 
Sertraline 0.29  420  25 
Venlafaxine 8.9  1060  9300 
Adapted from [1] and [2]. * Ki data for rat transporters. 480    Current Neuropharmacology, 2011, Vol. 9, No. 3  Williams et al. 
  Then we address behavioral alterations following drug 
exposure and highlight the serotonergic signaling changes 
that may contribute to these effects. Finally, we present an 
hypothetical model of how the differences in serotonergic 
development may contribute to changes in adult serotonergic 
function and how early environmental stress may interact to 
compound the negative effects of PC exposure. Additionally, 
we discuss possible factors influencing vulnerability to the 
effects of PC exposure including genetic variance and sex.  
  This review focuses primarily on the human literature 
and corresponding preclinical rodent studies. Studies of the 
effects of PC exposure have also been performed in non-
human primates, but have thus far focused on dopaminergic 
signaling systems. Although several such behavioral studies 
indicate 5-HT systems are worthy of study few such studies 
exist to date. All reviewed literature is divided into four 
postnatal developmental stages: 1) Infancy (defined as post-
natal days (PND) 1-10 in the rodent, Age 0-2 years in hu-
mans; 2) Juvenile: PND 11-25 in rodent, Age 2-12 in hu-
mans; 3) Adolescence: PND 26-50 in rodents, Age 12-20 in 
humans; 4) Adult: PND 51-forward in rodents, Age 21-
forward in humans). Unfortunately, little is known about 
specific changes in central nervous system (CNS) 5-HT 
function during the embryonic period when PC or prenatal 
antidepressant exposure is ongoing. Future studies should 
address this question to fully determine the time course of 
effects.  
  Table 2 presents a summary of the effects of PC exposure 
on the 5-HT system components, which is also presented 
throughout the text. Studies of prenatal drug exposure vary 
in their dosage and timing of drug administration, and these 
are important considerations when interpreting effects.  
  Experimental design differences are noted in Table 2 and 
throughout the text for animal literature, since reliable de-
tailed descriptions of dose and length of exposure are not 
commonly available for clinical datasets. Additionally, the 
majority of clinical studies combine women on several dif-
ferent types of antidepressants into one group, therefore 
throughout the review we have listed the drugs included in 
each study for clarification of potential variability of the ef-
fects. It should be noted, however, that a majority of behav-
ioral and biochemical studies have used similar doses, which 
were initially chosen to mimic doses achieved by drug-
abusing women [45]. 
B. SEROTONERGIC SIGNALING THROUGHOUT 
DEVELOPMENT 
1. S100, a Glial-derived Growth Factor for Serotonin 
Neurons 
  Astrocytic release of S100, regulated by 5-HT1A recep-
tors, acts as a trophic factor for 5-HT neurons, such that less 
S100 results in reduced survival of these neurons [46]. 5-
HT neurons begin differentiation early in gestation and 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Serotonergic Synapse. This diagram shows a serotonergic presynaptic neuron on the left. This presynpatic neuron is drawn to show 
release of 5-HT (rectangles) into the synapse. The released 5-HT can act on many substrates. 5-HT can bind to postsynaptic receptors (on 
right of figure) including g-protein coupled receptors 5-HT1A and 5-HT2A (solid circles) and ionotropic receptors like 5-HT3 (hollow circle). 
5-HT can act on presynaptic neurons through inhibitory autoreceptors (5-HT1A; solid circle in perisynaptic region) and 5-HT transporters. 
The 5-HT transporter (SERT: arrow box), brings 5-HT back into the axonal bouton. 5-HT is removed from the synapse through metabolic 
enzymes MAO and COM-T. 5-HT neurons receive trophic signals from astroglial cells during development and possibly throughout life via 
S100 (rectangle in astroglial cell). This diagram also includes other transporters for comparison. The dopamine transporter (DAT: arrowed 
box) is responsible for removing dopamine from synapses. The norepinephrine transporter (NET: arrowed box) is responsible for removing 
norepinephrine from the synapse. All three transporters are blocked by cocaine and to some extent antidepressants. Black arrows represent 
the relative ability of each compound to affect the transporters (binding affinities can be found in Table 1). Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors  Current Neuropharmacology, 2011, Vol. 9, No. 3    481 
Table 2.  PC exposure and 5-HT Signaling in Rodent Models 
Developmental Timeline 
Brain Region 
Exposure 
Length 
Dose 
(mg/kg/day) 
Infancy 
PND 1-10 
Juvenile 
PND 11-25 
Adolescence 
PND 26-50 
Adulthood 
PND 51- 
Refs 
Cortex 
1-20 
 
 
2-21 
 
8-20 
13-20 
 
30 
30 
 
30 
 
40 
40 
30 
30 
30 
30 
30 
 S100 (ns) 
F/M 5-HT1A 
- 
- 
 
- 
 S100 
- 
- 
- 
 SERT 
- 
- 
- 
- 
- 
- 
 
- 
- 
M 5-HT, stimulated  
5-HT release 
 5-HIAA 
- 
- 
- 
- 
- 
 F/M 5-HT1A 
- 
M 5-HT 
M 5-HIAA 
M 5-HT 
- 
M 5-HT 
 5-HIAA 
M 5-HT 
 SERT  
 5-HT1A 
 5-HT2A 
- 
F/M 5-HT1A 
 5-HT2A 
M 5-HT 
M 5-HIAA 
M 5-HT 
- 
M 5-HT M stimulated  
5-HT release 
M 5-HIAA 
- 
 SERT  
 5-HT1A 
 5-HT2A 
[49] 
[93] 
[109] 
[70] 
 
[50] 
[48] 
[62] 
 
[43] 
[50,80] 
[81,94] 
[74,90] 
[45, 90,109] 
Striatum 
and 
Nucleus Ac-
cumbens 
1-20 
 
 
2-21 
 
7-20 
 
 
8-20 
13-20 
 
15-21 
30 
30 
30 
 
 
30 
30 
30 
30 
30 
30 
40 
 S100 (ns) 
F/M 5-HT1A 
- 
- 
- 
 5-HT 
 Stimulated 5-HT 
 SERT 
- 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
M SERT 
M 5-HT, stimulated 
 5-HT release 
 5-HIAA 
- 
- 
F/M 5-HT1A 
- 
M 5-HT  
M 5-HIAA 
- 
- 
- 
M/M SERT 
-  
- 
- 
- 
F/M 5-HT1A 
 5-HT2A 
 P60 M/P180 M 5-HT 
P180 M 5-HIAA 
- 
- 
- 
M SERT 
M 5-HT /M stimulated 
 5-HT release 
 5-HIAA 
F/F/M 5-HT3 activity 
[49] 
[93] 
[109] 
[70] 
 
[69] 
 
 
[50,81] 
[62] 
 
[99,117] 
Hippocampus 
1-20 
 
2-21 
 
8-20 
 
13-20 
 
 
30 
30 
30 
 
30 
40 
40 
 
30 
30 
30 
 S100(ns) 
F/M 5-HT1A (ns) 
- 
 
- 
- 
 S100 
- 
- 
- 
 SERT 
- 
- 
- 
 
 M SERT 
- 
- 
- 
M 5-HT, stimulated 5-HT  
 5-HIAA 
- 
- 
- 
M 5-HT 
M 5-HIAA 
- 
M 5-HT 
- 
M SERT 
M 5-HT  
 
M SERT 
- 
F/M 5-HT1A 
 M 5-HT 
 M 5-HIAA 
M SERT 
M 5-HT 
- 
- 
M 5-HT, stimulated 5-HT  
 5-HIAA 
 M SERT 
[49] 
[93] 
[70] 
 
[81] 
[50] 
[43] 
[50] 
[62] 
 
[50,80] 
Hypothalamus 
2-21 
 
13-20 
 
 
 
 
30 
 
30 
- 
- 
- 
- 
- 
- 
- 
- 
- 
M 5-HT  
- 
 (M) 5-HT, stimulated 
 5-HT Release 
 5-HIAA 
- 
- 
- 
- 
- 
 M 5-HT 
 M 5-HIAA 
- 
- 
 SERT  
 5-HT1A,  
F/M 5-HT1A activity 
 5-HT2A 
5-HT2A activity 
 M 5-HT 
P60 M/P90 M 5-HIAA 
M 5-HT, stimulated 
 5-HT release 
 5-HIAA 
 SERT  
 5-HT1A 
M 5-HT1A activity 
 5-HT2A 
 5-HT2A activity 
[70] 
 
[62] 
 
[81,94] 
[81,94] 
 
[90, 105] 
[109] 482    Current Neuropharmacology, 2011, Vol. 9, No. 3  Williams et al. 
Table 2. contd…. 
Developmental Timeline 
Brain Region 
Exposure 
Length 
Dose 
(mg/kg/day) 
Infancy 
PND 1-10 
Juvenile 
PND 11-25 
Adolescence 
PND 26-50 
Adulthood 
PND 51- 
Refs 
Midbrain 
1-20 
 
 
13-20 
 
30 
30 
 
30 
 
30 
 S100 
F/M5-HT1A (ns) 
- 
- 
- 
 SERT 
- 
- 
- 
- 
- 
 M 5-HT,  M stimulated 5-HT 
 5-HIAA 
- 
 5-HT1A 
- 
- 
F/M 5-HT1A 
- 
- 
- 
 SERT  
- 
- 
- 
F/M 5-HT1A 
 5-HT2A 
M 5-HT, M 
stimulated 5-HT 
 5-HIAA 
- 
 5-HT1A 
 5-HT2A 
[49] 
[93] 
[109] 
[62] 
 
[69] 
[94] 
[109] 
Hindbrain 
1-20 30 
30 
30 
 S100 (ns) 
F/M 5-HT1A 
- 
- 
- 
- 
- 
F/M 5-HT1A 
- 
- 
F/M 5-HT1A 
 5-HT2A 
[49] 
[93] 
[109] 
The effects of PC exposure on various 5-HT signaling components throughout the brain and throughout development are diagramed above. Brain regions were operationally   
defined by individual authors. Exposure length is the number of days during gestation that fetuses were exposed to cocaine, listed in order of longest to shortest exposure   
lengths. Dose is described by the total milligrams of cocaine per kilogram of body weight given to the mother per day. Many studies reduced the dose and administered cocaine  
two or more times daily to achieve the total dose. The references column denotes references as listed in the bibliography and indicates references for information in each row.  
Each signaling component  (i.e. 5-HT or SERT) has a row for each brain region, unless there were no results to summarize. The arrows indicated the direction of change   
from control animals:  indicates no change,  indicates decrease caused by PC exposure, indicates an increase caused by PC exposure. Abbreviations: PND: postnatal day,  
SERT: serotonin transporter, ns: not significant. 
continue through the first postnatal week in rodents [47-49], 
suggesting that S100 activity remains critical during   
infancy. S100 can be quantified using techniques such as 
semi-quantitative immunobinding assays on brain sections 
[50] or luminescence assays in circulating biological fluids 
[51]. Additionally, S100 can be localized using immunocy-
tochemical techniques [52]. 
1.1. Infancy  
PC Exposure 
  Rats prenatally exposed to cocaine (30 mg/kg/day) from 
gestational day (GD) 1-20 show a significant decrease in 
S100 immunobinding in the midbrain, and non-significant 
decreases in the hindbrain (including the raphe nuclei), ven-
tral hippocampus, basal ganglia and forebrain on postnatal 
days (PND) 1 and 4, and exhibit a trend for decreases on 
PND 10 in all brain regions assessed [53]. PC exposure for 
only the last week of gestation (GD 13-20; 40 mg/kg/day), 
which is equivalent to the second trimester in humans, re-
sults in decreases in S100 in the hippocampus and the sub-
plate of cortex in PND 7 rats, which is reversed by 5-HT1A 
agonists for the first 5 PNDs [52,54]. These PC exposure-
dependent decreases in S100 delayed neonatal astroglial 
development in male rats at PND 6 [55]. 
SSRI Exposure 
  Chronic prenatal SSRI exposure has been shown to de-
crease plasma S100 at birth in human infants, suggesting 
that elevated levels of 5-HT, as a result of blocking re-
uptake, may down regulate circulating S100. The impact on 
CNS S100 and developing 5-HT neurons remains to be 
determined [56]. 
 
1.2. Juvenile, Adolescent and Adult Periods  
PC Exposure 
  The impact of PC exposure on S100 expression in juve-
niles, adolescents, or adults in either clinical populations   
or preclinical models has not been assessed. Adult chronic 
cocaine use does not alter circulating S100 levels in men 
[51], suggesting that the fetal period may be an especially 
sensitive window.  
SSRI Exposure 
  Relatively little is known concerning the effects of prena-
tal SSRI exposure on S100 in juveniles, adolescents or 
adults. Unlike cocaine, antidepressants can alter circulating 
S100 when taken during adulthood [57-59], indicating the 
importance of future studies at these later time points. 
1.3. Summary 
  Given that PC exposure decreases early S100 expres-
sion and causes deficits in gliogenesis from infancy that last 
through adulthood [55,60], and that S100 regulates 5-HT 
neuronal growth and survival, it is possible that low levels of 
S100 in infancy may result in long term effects on 5-HT 
neurons, astrocytes, and associated neuro-glial interactions. 
Although these effects may be most evident in the raphe nu-
clei, they likely will also occur in brain regions innervated by 
5-HT terminals. Future studies directly measuring the affect 
of PC exposure on S100 at time points later than infancy in 
different brain regions will be important to properly evaluate 
this possibility.  
  These data suggest that levels of S100 may be lower 
during infancy following any type of prenatal SERT blockade  
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(SSRI or cocaine). This could lead to deficits in 5-HT   
neuronal survival or deficits in associated astrocyte function-
ing that might persist into adulthood. Future studies should 
address whether effects observed in infancy are transient   
or have long-lasting effects. Since S100 serves important 
functions both centrally and peripherally in the adult nervous 
system and has been tied to developmental disorders such  
as schizophrenia, autism, Down Syndrome, depression, and 
bipolar disorder [61-65], many of which have also been as-
sociated with PC exposure (See Section C. Behavioral 
Consequences of Prenatal Drug Exposure), these studies 
could prove very important in determining the full spectrum 
of effects of PC and SSRIs on the serotonergic system.  
2. Serotonin Levels and Neuronal Growth Throughout 
Life 
  Serotonin neurons and fibers can be studied using stan-
dard immunocytochemical techniques [54] and quantified 
using immunobinding methods on tissue sections, whereas 5-
HT levels are commonly measured using high-pressure liq-
uid chromatography (HPLC) [66,67]. p-Chloroamphetamine 
(PCA) is a common pharmacologic approach to stimulate 
release of 5-HT at synapses [68], which has been used effec-
tively to investigate the effects of PC and SSRI exposure on 
5-HT release. It is extremely difficult to accurately measure 
5-HT (even peripherally) in humans, because of its rapid 
metabolism. Thus, our knowledge of the effects of PC and 
SSRIs on human 5-HT content is sparse. However, CNS 5-
HT levels can be inferred by monitoring for 5-HT syndrome, 
a disorder observed in humans and rodents, which exhibit 
myoclonus, restlessness, tremor, shivering, hyperreflexia, 
incoordination and rigidity [69]. Therefore, the rodent litera-
ture regarding the consequences of PC or prenatal SSRI   
exposure is primarily reviewed here.  
2.1. Prenatal Period 
PC Exposure 
  Following a week of mid-gestational cocaine exposure 
(GD 8-12; 40 mg/kg/day), 5-HT striatal levels were in-
creased in fetal mice (GD 18), indicating that PC exposure 
affected late fetal serotonergic development [67]. This is 
especially noteworthy since SERT expression in 5-HT neu-
rons has not yet begun during this exposure period [70], sug-
gesting that PC exposure alters 5-HT through mechanisms 
other than CNS SERT blockade during early gestation. 
SSRI Exposure 
  SSRIs can block 5-HT uptake into non-neuronal tissues 
in the craniofacial region or placenta, although their effects 
on CNS 5-HT is unclear [71-73]. 
2.2. Infancy  
PC Exposure 
  PC exposure over the last 2 weeks of gestation (GD 7-20; 
30 mg/kg/day) does not change spontaneous release of 5-HT, 
but does result in decreased stimulated 5-HT release in the 
striatum and nucleus accumbens in both males and females 
[74], suggesting altered presynaptic regulation. Future   
studies to determine the effects of PC exposure by direct 
quantification of 5-HT levels and stimulated 5-HT release   
in other brain regions, including the raphe nuclei, would help 
determine whether these effects are specific to the striatum 
and nucleus accumbens.  
SSRI Exposure 
  No data are currently available regarding changes in 5-
HT levels during infancy following prenatal SSRI exposure. 
However, infants exposed to fluoxetine or citalopram 
throughout gestation are more likely to exhibit 5-HT syn-
drome, especially those infants with alleles for slower 5-HT 
metabolism [75,76]. 
2.3. Juvenile and Adolescent Periods  
PC Exposure 
  Following PC exposure over 2 weeks in late gestation 
(GD 13-20; 30 mg/kg/day) or throughout gestation (GD 2-
21; 30 mg/kg/day), juvenile male rats showed no differences 
in 5-HT content in cortex, striatum, hypothalamus or mid-
brain [66,77]. PCA-stimulated 5-HT release was increased in 
the midbrain, but not in other brain regions assessed (e.g., 
cortex, hippocampus, hypothalamus, and striatum) [66]. Al-
though 5-HT levels in the raphe were not assessed, these 
findings suggest that while production of 5-HT is unaffected 
by PC exposure, 5-HT release is likely impacted through 
effects on exocytotic mechanisms, SERT, or inhibitory auto-
receptors (5-HT1A). Potentially, developmental compensa-
tions for increased basal 5-HT levels in infancy could also 
play a role [74]. PC exposure (GD 8-20; 40 mg/kg/day) was 
also associated with decreased 5-HT nerve terminals in ado-
lescent male rat hippocampus, with no change detected in 
cortex [54].  
SSRI Exposure 
  Following prenatal fluoxetine exposure (GD 13-20; 10 
mg/kg/day), no differences were found in 5-HT content (as 
measured by HPLC) in hippocampus, striatum, or hypo-
thalamus, although decreases in cortical 5-HT were observed 
in adolescent male rats [78], an effect not observed following 
PC exposure. Interestingly, prenatal exposure to another an-
tidepressant (amitriptyline; GD 2-21; 10 mg/kg/day), which 
blocks both 5-HT and NE transporters, decreased basal lev-
els of 5-HT in the striatum (but not prefrontal cortex, hippo-
campus, hypothalamus, or amygdala) of adolescent rats [78], 
indicating a complex interaction between serotonergic and 
noradrenergic mechanisms in the control of 5-HT release. 
2.4. Adulthood 
PC Exposure 
  Following PC exposure (GD 13-20; 30 mg/kg/day), 
lower levels of 5-HT were found in the adult rat cerebral 
cortex and hippocampus, with no effect on the midbrain or 
hypothalamus, or on PCA-induced 5-HT release in any brain 
region assessed during adulthood [66]. In contrast, a longer 
period of PC exposure (GD 2-21; 30 mg/kg/day) in rats is 
correlated with a transient decrease in striatal 5-HT in early 
adulthood, that normalized to control levels by late adult-
hood [77]. These data suggest that 5-HT fibers may be dete-
riorating with age in the hippocampus and cortex, given that 
no difference was observed during the juvenile and adoles-
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SSRI Exposure 
  Following prenatal fluoxetine exposure (GD 13-20; 10 
mg/kg/day), no differences in 5-HT release were observed in 
adulthood in any of the same brain regions measured in ado-
lescents, except for a decrease in basal 5-HT in midbrain 
[78]. Prenatal exposure to amitriptyline (GD 2-21; 10 
mg/kg/day) had no effect on 5-HT in male rats in any of the 
regions assessed during adolescence [77]. There were no 
changes in PCA-induced 5-HT release in any brain region, 
except midbrain in adult male rats, where release was de-
creased by prenatal exposure to fluoxetine, an effect opposite 
to that seen after PC exposure [78]. 
2.5. Summary 
  Studies have thus far focused on male rodents, leaving 
regional investigation of the effects of PC exposure on 5-HT 
content and release in females essentially unexplored. This 
body of evidence indicates that the impact of PC exposure on 
5-HT content and release is dependent upon the age of test-
ing and brain region assessed. A more thorough quantifica-
tion of 5-HT neurons and fibers throughout the brain in both 
genders is needed, since sex-related behavioral changes are 
apparent (see Section C. Behavioral Consequences of Pre-
natal Cocaine Exposure). It is clear that effects of PC expo-
sure on basal and stimulated 5-HT release, as well as other 
signaling systems that impact 5-HT neuronal growth, sur-
vival and function may depend on a number of serotonergic 
factors that can also be disrupted by PC exposure. 
  Differences between the effects of PC and prenatal SSRI 
exposure on 5-HT release suggest that PC exposure may 
impact development of 5-HT neurons through mechanisms 
other than SERT blockade, especially given the observed 
impact of very early PC exposure [77]. SERT is not ex-
pressed in CNS tissue until GD 12 in rats [70], therefore the 
action of cocaine on SERT at earlier time points likely oc-
curs through another mechanism, such as cocaine-induced 
changes in neuronal growth, trophic factors (e.g. S-100; see 
Section B.1.1) or 5-HT1A activity (See Section B.5.1). 5-
HT1A signaling is important for the developmental functions 
of S100, which have been shown to be disrupted by PC 
exposure during infancy [53], a period of rapid neurite out-
growth and synaptogenesis, thus potentially dysregulating 
appropriate connections or presynaptic mechanisms. Differ-
ences observed between cocaine (SERT/NET/DAT block-
ade), amitriptyline (SERT/NET blockade) and fluoxetine 
(SERT blockade), highlight the impact of PC exposure on 
the interaction between multiple monoamine signaling sys-
tems during infancy, which may underlie the differences 
between effects of PC and prenatal SSRI exposure on adult 
5-HT levels. For example, NE signaling has been suggested 
to alleviate some 5-HT syndrome symptoms during infancy 
[76]. Therefore, a possible explanation for the differences 
between PC and prenatal SSRI exposure may be the in-
creased synaptic NE. Unfortunately, few studies have inves-
tigated this potential mechanism and future work would be 
greatly informative.  
3. Serotonin Metabolism 
  Serotonin is rapidly metabolized by monoamine   
oxidase (MAO-A) into a long-lasting compound, 5-
Hydroxyindoleacetic acid (5-HIAA), which can be used as a 
metric for basal 5-HT levels and turnover (5-HT/5-HIAA 
ratio). In human populations, low plasma and cerebrospinal 
fluid (CSF) levels of 5-HIAA have been measured   
with HPLC and tied to suicidal and aggressive behaviors 
[79,80].  
3.1. Infancy 
PC Exposure 
  Human PC exposed infants show no differences in CSF 
levels of 5-HIAA [81], and no published results exist that 
utilize animal models to study infant levels of 5-HIAA. 
However, given the suggestion that 5-HT levels are lower 
during infancy following PC exposure, it is reasonable to 
hypothesize that 5-HIAA would be lower as well, although 
this has not been directly tested. Additionally, cocaine can 
increase MAO-A activity, which is interesting since MAO-A 
is expressed as early as GD 12 in rats [67,82,83], providing a 
possible mechanism through which PC exposure could im-
pact 5-HT metabolism. Fetal 5-HIAA measurements could 
be obtained given the fact that increased 5-HT has been ob-
served during the fetal period following PC exposure in mice 
[67]. Taken together, these data would suggest a possible 
disruption in fetal 5-HT metabolism by PC exposure. 
SSRI Exposure 
  No studies have been published regarding infant levels of 
5-HIAA in animal models following prenatal SSRI exposure. 
Infants exposed to either fluoxetine or citalopram throughout 
gestation show reduced 5-HIAA in the cord blood in the first 
few days of life [75]. 
3.2. Juvenile and Adolescent Periods 
PC Exposure 
  In juvenile male and female rats, PC exposure (GD 2-
21;10 mg/kg/day) or (GD 13-20; 30 mg/kg/day) does not 
significantly alter 5-HIAA levels in the striatum, hippocam-
pus, prefrontal cortex or midbrain [66,77]. These data   
are similar to those found for the effect of PC exposure on  
5-HT, suggesting that 5-HT metabolism is likely unaffected 
at this age. 
SSRI Exposure 
  Prenatal fluoxetine exposure (GD 13-20; 10 mg/kg/day) 
does not affect 5-HIAA or the 5-HT/5-HIAA ratio in the 
cortex, hippocampus, striatum, midbrain or hypothalamus 
during adolescence in male rat offspring [78].  
3.3. Adulthood  
PC Exposure 
  Male and female rats exhibit no differences in 5-HIAA 
levels, other than a reported decrease in male hypothalamus 
by adulthood following PC exposure (GD 2-21; 30 
mg/kg/day) [77]. This is particularly intriguing given that 
with the same PC exposure, adult rats had lower 5-HT levels 
in the hippocampus and cortex (see Section B. 2.4 in Sero-
tonin Levels and Neuronal Growth Throughout Life). 
This suggests that there may be changes in the rate of 5-HT 
metabolism in PC exposed rodents that does not appear until 
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SSRI Exposure 
  Prenatal fluoxetine exposure (GD 13-20; 10 mg/kg/day) 
in rats had no effect on 5-HIAA levels in any brain region 
[78]. Since there is decreased 5-HT in the midbrain of adult 
rats, this indicates a potential deficit in metabolism due to 
prenatal SSRI exposure that may be specific to the midbrain 
[78]. Exposure to amitriptyline (GD 2-21; 10 mg/kg/day) 
during the same period results in a transient decrease in   
striatal 5-HIAA at PND 60 in male rats, similar to what is 
observed with 5-HT levels, suggesting no effect on 5-HT 
metabolism [77]. 
3.4. Summary 
  PC exposure seems to impact the hypothalamus and hip-
pocampus to a greater extent than other brain regions [77]. 
This suggests that interactions between cellular signaling 
components may differ in these regions in response to SERT 
blockade, although this needs to be directly tested. Future 
studies could also explore whether exposure to SSRIs would 
cause similar changes in males and females following longer 
exposure paradigms.  
  Interestingly, susceptibility to the negative impact of   
prenatal SSRI exposure in human infants appears to be   
dependent on genetic variance in MAO-A and c-O-
methyltransferase (COMT), another 5-HT metabolic en-
zyme. Specifically, individuals who rapidly metabolize 5-HT 
when exposed to SSRIs show greater 5-HT syndrome symp-
toms [76]. Given that cocaine can enhance MAO-A activity 
[82], both PC and prenatal SSRI exposure appear to result in 
regionally-specific changes in 5-HT metabolism (see Section 
B.2.4 Serotonin Levels and Neuronal Growth Throughout 
Life), and changes in 5-HT metabolism that are involved   
in depression and aggression [79,80]. Children with these 
exposure histories should be carefully monitored as they 
mature.  
4. Developmental Effects on Serotonin Reuptake Sites 
  Sites of 5-HT reuptake (expression of the serotonin 
transporter, SERT) are important for maintaining serotoner-
gic tone by recycling synaptic 5-HT back into presynaptic 
serotonergic nerve terminals. Importantly, these are sites   
of direct action of both SSRIs, and non-selective serotonin 
reuptake inhibitors (SRIs) including cocaine, which bind   
and block 5-HT transport [39,84]. SERT can be measured  
by immunobinding or binding assays using known SERT 
binding drugs such as, citalopram or paroxetine, and is   
found throughout the brain and is well known for its   
involvement in mood regulation [54,78,84]. Not surprisingly, 
SERT is impacted by prenatal exposure to both cocaine and 
SSRIs. 
4.1. Infancy  
PC Exposure 
  PC exposure (GD 13-20; 30 mg/kg/day) in rats causes a 
decrease in cortical and hippocampal 5-HT uptake sites from 
PND 1-7 in both males and females [54,85]. Moreover, re-
duced citalopram binding is seen in the striatum and nucleus 
accumbens, but not the midbrain, of males and females at 
PND 7 following a longer PC exposure (GD 7-20; 30 
mg/kg/day ) [74].  
SSRI Exposure 
  To date there are no studies that have directly investi-
gated the effects of SSRIs on SERT expression or activity 
during infancy in either clinical or preclinical models. 
4.2. Juvenile and Adolescent Periods  
PC Exposure 
  PC exposure (GD 8-20; 40 mg/kg/day) results in in-
creased SERT binding in the nucleus accumbens without 
affecting the striatum or hippocampus during the juvenile 
period [86]. Studies measuring increased PCA-stimulated 5-
HT release suggested that PC exposure (GD 13-20; 30 
mg/kg/day) may also increase SERT expression in the mid-
brain of juvenile male [66]. This reliable method of increas-
ing synaptic 5-HT is partially driven by PCA competitively 
antagonizing SERT; therefore, a greater number of PCA 
action sites indirectly suggests more SERT to explain the 
enhanced 5-HT release [68]. In contrast, during adolescence, 
PC exposure (GD 13-20; 40 mg/kg/day) decreased SERT 
binding in the nucleus accumbens in male rats, with no effect 
in the hippocampus or striatum [54].  
SSRI Exposure 
  Fluoxetine (GD 1-21; 2.5 mg/kg/day) and chlorim-
pramine (GD 1-21; 10 mg/kg/day) result in 30% reduction in 
cortical SERT binding sites at PND 25 [87]. Although early 
studies found no differences in SERT in the cortex, striatum, 
hippocampus, midbrain or hypothalamus of juvenile male 
rats following prenatal fluoxetine exposure (GD 13-20; 10 
mg/kg/day) [78], more detailed anatomical analyses have 
indicated increased expression during the juvenile period in 
the basolateral and medial amygdala, CA2 and CA3 regions 
of the hippocampus and the lateral hypothalamus. In con-
trast, a decrease in SERT expression was reported in the dor-
somedial hypothalamus in the same animals [88]. These data 
suggest that the length of exposure or dose may play impor-
tant roles in the development of SERT expression, especially 
in the cortex since opposite results were reported in these 
studies. More anatomically detailed investigations following 
various exposure lengths and doses could determine the full 
impact of SSRI exposure on juvenile SERT. 
4.3. Adulthood  
PC Exposure 
  PC exposure (GD 8-20; 40 mg/kg/day) has no impact on 
SERT expression in the striatum, nucleus accumbens or hip-
pocampus of adult rats [86]. Surprisingly, little is known 
about the impact of PC exposure on adult SERT expression 
in other brain regions, particularly cortex where effects are 
seen earlier in development. Moreover, the studies per-
formed thus far have not included females, although SERT 
activity certainly varies across gender [89,90]. 
SSRI Exposure 
  Several studies have reported no change in SERT expres-
sion in adult rats following prenatal fluoxetine exposure (GD 
13-20; 10 mg/kg/day) [78,88]. Early studies measured SERT 
in the cortex, striatum, hippocampus, midbrain, and hypo-
thalamus [78], and later reports focused on specific sub-
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and dorsomedial nuclei of the hypothalamus; the CA3 and 
CA2 regions of the hippocampus, and the basolateral and 
medial nuclei of the amygdala [88]. Fluoxetine (GD 1-21; 
2.5 mg/kg/day) and chlorimpramine (GD 1-21; 10 mg/kg/ 
day) do not effect cortical SERT binding sites at PND 90 
[87]. These negative results mirror those observed following 
PC exposure. However, a recent study has shown a 35% de-
crease in SERT immunoreactivity in the raphe nuclei of rats 
on PND 120 following fluoxetine exposure from GD 14-
PND 7 [91]. 
4.4. Summary 
  Taken together, these results suggest that PC exposure 
studies should investigate changes in SERT expression with 
higher anatomical resolution in the future, similar to studies 
with prenatal SSRIs, where differences emerged only when 
brain regions were examined in more detail. Adolescence 
might prove to be a particularly good developmental time 
point for such analysis, since the greatest differences were 
seen following SSRI exposure in this group. Additionally, it 
would appear that early disruption (until early adolescence) 
of SERT expression normalizes by adulthood, with the nu-
cleus accumbens exhibiting the greatest change throughout 
development. Studies that pinpoint developmentally dynamic 
changes in SERT expression and activity following PC ex-
posure would be informative, especially in the context of 
SERT-dependent behavioral changes. Few studies have ex-
amined the impact of prenatal exposure to either cocaine or 
SSRIs on female SERT expression. Given that SERT is 
regulated differently in males and females [38,89,92,93], it 
will be important to determine if females are equally   
impacted by PC or prenatal SSRIs. 
5. 5-HT1A Receptors 
 5-HT1A receptors serve a variety of functions, acting as 
both presynaptic autoreceptors on 5-HT neurons in the raphe 
nuclei [94] and as postsynaptic receptors on neurons inner-
vated by 5-HT axons throughout the brain, particularly in 
limbic areas, cingulate and prefrontal cortices [34,95]. These 
receptors are also expressed on astrocytes, which release S-
100, a growth factor for 5-HT neurons, as discussed above. 
Additionally, 5-HT1A receptors in the hypothalamus contrib-
ute to stress-induced release of adrenocorticotrophic hor-
mone (ACTH), corticosterone (the rodent equivalent of cor-
tisol), renin, prolactin and oxytocin into the bloodstream by 
the pituitary [96]. Consequently, this receptor has received 
the most attention in PC exposure studies.  
5.1. Infancy  
PC Exposure 
  Following full gestational PC exposure (GD 1-20; 30 
mg/kg/day), male rats on PND 1 show significantly in-
creased 5-HT1A receptors in the raphe nuclei, basal ganglia 
and forebrain, and non-significant increases in the hippo-
campus and substantia nigra as measured by semi-
quantitative
 125I-protein A immunobinding (Fig. 2), in con-
junction with an increase in 5-HT1A mRNA in brainstem 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). The Impact of Prenatal Cocaine Exposure on 5-HT1A Receptors is Region-Specific. Immunobinding data are represented as percent 
control means ± SEM (i.e. PC exposed males compared to Control Males). Asterisks (*) represent that PC exposed males differed signifi-
cantly from control males (p  0.05). Pound signs (#) represent that PC exposed females differed significantly from control females (p  
0.05). Infancy: PND 1, Adolescence: PND 30, Early Adult: PND 60, Late Adult: PND 120. Insets display representative anatomical sections 
from which immunobinding data was collected. PND: postnatal day. Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors  Current Neuropharmacology, 2011, Vol. 9, No. 3    487 
[50,53]. However by PND 10, 5-HT1A immunobinding nor-
malizes in the midbrain, but continues to show decreases in 
the basal ganglia/forebrain and hindbrain in conjunction with 
reduced 5-HT1A mRNA expression [53]. In contrast, females 
exhibit decreased 5-HT1A receptors in the raphe nuclei, hip-
pocampus, basal ganglia and forebrain on PNDs 1 and 10 
[50,53] (see Fig. 2).  
SSRI Exposure 
  To date there are no studies that have directly investigated 
the effects of SSRIs on 5-HT1A receptors expression or activity 
during infancy in either clinical or preclinical models.  
5.2. Juvenile and Adolescent Periods  
PC Exposure 
  PC exposure (GD 13-20; 30 mg/kg/day) does not affect 
5-HT1A receptors in cortex, hypothalamus or midbrain of 
prepubescent male or female rats, as measured by radio-
ligand binding assays [85,97]. This exposure paradigm does 
result in increased 5-HT1A-stimulated release of ACTH and 
renin in juvenile males, but not females [85], without impact-
ing basal release. These data suggest altered activity without 
a concurrent change in expression. Following longer PC ex-
posure (GD 1-20; 30 mg/kg/day) male 5-HT1A immunobind-
ing throughout the brain is not altered during adolescence 
(PND 30), although females show reduced receptor im-
munobinding across all brain regions examined with the ex-
ception of the dorsal hippocampus and amygdala [53,50] 
(see Fig. 2).  
SSRI Exposure 
  To date there are no studies that have directly investi-
gated the effects of SSRIs on 5-HT1A receptor expression or 
activity during juvenile or adolescent periods in either clini-
cal or preclinical models. 
5.3. Adulthood  
PC Exposure 
  PC exposure (GD 13-20; 30 mg/kg/day) does not affect 
5-HT1A receptors in the cortex, hypothalamus or midbrain of 
adult male or female rats, as measured by radioligand bind-
ing assays at PND 70 [85,97]. Receptor dynamics (produc-
tion, degradation and half life) are also unaffected in adult-
hood by this exposure paradigm [98]. Unlike adolescents, 
adults show no change in 5-HT1A-stimulated release of any 
hypothalamic hormone, and also have normal basal hormone 
levels [85]. Chronic paroxetine administration desensitizes 5-
HT1A  receptors [99] and PC exposure (GD 13-20; 30 
mg/kg/day) decreases 5-HT1A-stimulated ACTH release fol-
lowing a 2 week paroxetine treatment period in adult male 
but not female rats, indicating a differential, sex-specific 
sensitivity to alterations in serotonergic signaling following 
PC exposure [100]. PC exposure (GD 1-20; 30 mg/kg/day) 
alters brain 5-HT1A expression in a sex-specific manner 
(Figs. 2 and 3), as measured by semi-quantitative
 125I-protein 
A immunobinding [50,53]. During early adulthood (PND 
60), males have decreased 5-HT1A immunobinding in the 
raphe nuclei, hippocampus, substantia nigra, basal ganglia 
and forebrain, which remains low until PND 120. PC ex-
posed females exhibit reduced immunobinding in the raphe 
throughout development with other regions normalizing by 
puberty and remaining normalized throughout adulthood, 
with the exception of the forebrain, which shows a surge in 
5-HT1A binding during later adulthood (PND 120; Fig. 2).  
SSRI Exposure 
  A single study has shown that exposure to fluoxetine 
(GD 13-21; 8 or 16 mg/kg/day) or venlafaxine (GD 13-21; 
40 or 80 mg/kg/day) does not affect the response of adult rats 
to 5-HT1A agonist-induced 5-HT syndrome, suggesting that 
the function of these receptors is unchanged [101]. As men-
tioned above, since many of the differences in 5-HT1A recep-
tors are greater following PC exposure regimens with expo-
sure beginning prior to SERT expression [50,70], it is possi-
ble that other cocaine-induced effects are responsible for the 
observed changes.  
5.4. Summary  
  Immunobinding and radioligand binding are useful tech-
niques to study regional changes in receptor proteins, how-
ever, further studies are needed to determine whether such 
changes are in pre- or postsynaptic locations. Additionally, it 
will be important to determine whether receptor differences 
occur on neurons or glia since some controversy exists over 
cell-type specific expression [102,103]. 
  One important discrepancy noted in the literature is the 
difference between length of PC exposure and its effect on 
adult 5-HT1A receptor expression patterns. Exposure for only 
the last 2 weeks of gestation results in minor changes, while 
exposure for the entire gestational period has long-lasting 
effects in males, and to a lesser extent in females. This is 
especially apparent when immunobinding data are com-
pressed across brain regions (Fig. 3). This suggests that 
events occurring early in embryogenesis may have long-term 
consequences for 5-HT1A receptors. Moreover, since 5-HT1A 
expression and function are critical for a number of behav-
iors, the length and timing of exposures should be considered 
in future clinical studies.  
  These data also suggest a sex-specific effect on the 
stress-response as a function of 5-HT1A receptor activity in 
the hypothalamus. Future studies should investigate func-
tional changes in 5-HT1A receptors in different brain regions 
following longer PC exposure paradigms, since it is currently 
unclear whether earlier exposure will cause similar sex-
specific effects on 5-HT1A function. Since PC exposure does 
not appear to impact the ability of these receptors to promote 
release of oxytocin, prolactin, or corticosterone at any age in 
either sex [100], these results suggest a sensitivity of CRF 
releasing neurons to PC exposure, in contrast to other neu-
roendocrine cells of the hypothalamus. Although 5-HT may 
also be having a direct stimulatory effect on pituitary cells, 
the interactive roles of CRF and 5-HT in releasing ACTH 
remains unclear [104,105]. This system may be a critical 
point in behavioral stress response differences observed in 
these offspring (see Sections C. 3.3 C.3.4 on Hormonal 
and Behavioral Stress Response), and direct investigation 
of the CRF signaling system would be greatly informative. 
  Additionally, as can be seen in Fig. (3), the developmen-
tal age when PC exposure has effects on 5-HT1A receptors 
throughout the brain depends on sex. Given that the 5-HT1A 
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estrous cycle [106], and this was not taken into consideration 
during brain collection, the control females show a great deal 
of variability that PC exposed females do not. The estrous 
cycle does not appear to be disturbed in PC exposed females 
[107] suggesting that they may be less sensitive to endocrine 
control of their 5-HT1A receptors. Testosterone can inhibit 
the function and expression of 5-HT1A receptors [108,109], 
and although adult testosterone levels are unaffected by PC 
exposure, cocaine can alter testosterone incorporation into 
the hypothalamus, [110], potentially causing organizational 
effects that could impact reactivity to changes in the hormo-
nal milieu later in life. In addition, 5-HT1A receptor activity 
during the perinatal period is important for development of 
testosterone sensitivity and aggressive behavior in adulthood 
[111], which could be impacted by increased expression of 
5-HT1A receptors during the neonatal period, as has been 
observed in rodents [50]. It can be proposed that early co-
caine-induced changes in steroid hormonal signaling may 
predispose 5-HT1A receptors to disrupted interactions with 
adult hormonal signaling, an area where further research is 
warranted. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Whole brain 5-HT1A receptor immunobinding. Represented as 
percent control means ± SEM (i.e. PC exposed males compared to 
control males) for each sex. Asterisks (*) represent that PC exposed 
males differed significantly from control males (p  0.05). Pound signs 
(#) represent that PC exposed females differed significantly from con-
trol females (p  0.05). Infancy: PND1, Adolescence: PND 30, Early 
Adult: PND 60, Late Adult: PND 120 PND: postnatal day. 
  Alternatively, the sex differences observed may not rely 
solely on hormonal causes. The absence of SERT throughout 
development has sex-specific effects on 5-HT1A, specifically 
SERT knockout mice show decreased 5-HT1A in the raphe 
nuclei of males and females, but in females this effect is both 
more pronounced and found in several other brain regions 
[38]. Although these data do not mimic exactly what is seen 
after PC exposure, PC exposure does decrease SERT during 
infancy [74,85] (and potentially during embryogenesis, how-
ever this is not yet known), and this decreased SERT activity 
may be playing an important role in the development of   
5-HT1A signaling. Taken together, these data highlight the 
complexity of the developing serotonergic system. 
  Nonetheless, studies of the effects of prenatal SSRI expo-
sure on 5-HT1A expression and activity could be useful in 
deciphering the role of SERT blockade in 5-HT1A develop-
mental dysregulation, especially since prenatal SSRIs cause 
similar deficits in SERT expression in neonatal life as com-
pared to PC exposure (see Section B. 4.  Developmental 
Effects on Serotonin Reuptake Sites), which is a potential 
mechanism for disrupted 5-HT1A expression [38]. If such 
studies find that prenatal antidepressant exposure does not 
cause disruptive effects on 5-HT1A receptors similar to PC 
exposure, then this may warrant further investigation to un-
derstand how 5-HT1A receptor regulation occurs throughout 
development. Additionally, such differences might help ex-
plain the lack of many behavioral deficits seen following 
prenatal SSRIs compared to PC exposure (see Section C. 
Behavioral Consequences of Prenatal Cocaine Exposure).  
  Few studies have investigated how prenatal exposure to 
SSRI’s affects postnatal 5-HT1A receptor expression or func-
tion. However, given the role of 5-HT1A receptors in the de-
velopment of 5-HT syndrome, and SSRIs ability to increase 
the likeliness of this disorder, these receptors should be in-
vestigated [69]. 
6. 5-HT2A RECEPTORS 
 5-HT2A receptors, a subtype of 5-HT2 receptors, are dis-
tributed throughout the cortex, basal forebrain, hypothala-
mus, hippocampus and hindbrain [34,112]. 5-HT2A receptors 
have been strongly implicated in psychotic behavior [113], 
as well as contributing to impulsive behavior, depression and 
anxiety [114,115]. Similar to 5-HT1A receptors, 5-HT2A re-
ceptors contribute to the release of several hormones into the 
bloodstream in response to stress, and are commonly meas-
ured using receptor binding techniques [96,98].  
6.1. Infancy  
PC Exposure 
  There are no published data on whether expression or 
function of 5-HT2A receptors change following PC exposure 
in infancy.  
SSRI Exposure 
  There have been no studies investigating the effects of 
prenatal SSRI exposure on 5-HT2A receptors in infancy. 
6.2. Juvenile and Adolescent Periods  
PC Exposure 
  Male rats with PC exposure (GD 13-20; 30 mg/kg/day) 
exhibit increased ACTH and renin release following 5-HT2A 
stimulation in the hypothalamus as juveniles without 
changes in receptor density, similar to effects observed on 5-
HT1A function [112]. There are no data regarding differences 
in 5-HT2A receptor expression in the adolescent period fol-
lowing PC exposure.  
SSRI Exposure 
  Following prenatal exposure to fluoxetine (GD 13-20; 10 
mg/kg/day) or amitriptyline (GD 2-21; 10 mg/kg/day), 5-
HT2A receptor binding and function are unaffected in the 
hypothalamus and cortex of juvenile male and female rats 
[24,116-118]. This is in contrast to increased ACTH and 
renin release in adolescent PC exposed males. However, 
longer exposure (GD 6-21; 10 mg/kg/day) to chlorimi-
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in decreased 5-HT2 receptor binding in juvenile rats, while 
exposure to a different antidepressant, nomifensine (GD 6-
21; 10 mg/kg/day) (DA/NE reuptake inhibitor), increases 5-
HT2 receptor binding, [119]. Although, these studies   
using SRIs were not specific to 5-HT2A, they suggest a   
very complex mechanism controlling expression of this re-
ceptor. 
6.3. Adulthood  
PC Exposure 
  Following PC exposure (30 mg/kg/day) on GD 13-20 or 
on GD 1-20, both adult male and female rats showed no dif-
ferences in 5-HT2A receptor expression in the hindbrain, 
midbrain, hypothalamus or forebrain [112,120]. Receptor 
dynamics (production, degradation rate and half life) were 
also unaffected in adults following PC exposure [98], and no 
effect on adult basal function (to control hypothalamic hor-
mone release) of 5-HT2A receptors was observed. PC expo-
sure in male rats can lead to enhanced desensitization of hy-
pothalamic receptors following 2 weeks of paroxetine treat-
ment, while not affecting receptor expression, as measured 
by diminished ACTH and oxytocin responses to a 5-HT2A 
agonist [121]. Another study investigated the role of 5-HT2 
receptors in preventing fluoxetine-induced acetylcholine 
release in the striatum, and found that PC exposure had no 
effect in males or females, indicating function and sensitivity 
to 5-HT for these receptors were unchanged in this brain 
region [107]. Taken together, these results suggest that   
5-HT2A receptors in general are not greatly impacted by PC 
exposure, with the exception of the male hypothalamus 
[121].  
SSRI Exposure 
  Decreases in receptor binding are observed in adult males 
[24,113,117,118] and correspondingly, adult males exhibited 
an attenuated 5-HT2A-stimulated release of ACTH and renin 
[117]. This is in contrast to the lack of effects in adult PC 
exposed males. Little other work has been reported investi-
gating the impact on other 5-HT receptor subtypes following 
prenatal SSRI exposure. 
6.4. Summary 
  The results of prenatal SRI exposure are interesting in 
comparison to those of PC exposure, as the impact is 
stronger during adulthood, while PC exposed adults have 
recovered from differences observed in the juvenile period. 
This suggests that differential developmental compensations 
may be occurring because of the multiple mechanisms of 
cocaine, and highlights the importance of studying different 
developmental time points. This hypothesis is supported by 
data showing opposite effects on 5-HT2  receptor binding 
following SERT blockade compared to DAT/NET blockade. 
Since cocaine acts on all three transporters, it may negate the 
effects of DAT/NET blockade and return the system to natu-
ral development by adulthood, although this remains to be 
determined. 
7. 5-HT3 Receptors 
 5-HT3 receptors, the only ionotropic serotonin receptor, 
have been associated with drug abuse, aggression and de-
pression [122-124]. These receptors are expressed at the 
highest levels in the brainstem, but are also present at appre-
ciable levels in the hippocampus, amygdala, caudate-
putamen, and some cortical regions [34, 122-124]. Since 
these receptors modulate the release of acetylcholine in the 
forebrain; thus, stimulated acetylcholine release can be used 
as a metric for 5-HT3 activity [125]. 
7.1. Infancy, Juvenile and Adolescent Periods  
  No published studies have investigated 5-HT3 receptor 
changes following PC or SSRI exposure in infancy, juvenile 
or adolescent periods. 
7.2. Adulthood  
PC Exposure 
  To date, only a single lab has studied the effects of PC 
exposure on 5-HT3 receptor-induced acetylcholine release in 
the striatum of adult male and female rats [107, 125]. These 
studies indicated that PC exposure (40 mg/kg/day) from GD 
15-21 enhances 5-HT3 functional inhibition of acetylcholine 
release in males and diestrus females, but not in proestrus 
females. This suggests an interaction of PC exposure with 
reproductive hormonal status in 5-HT3 regulation of acetyl-
choline release, a finding that should be explored further at 
specific developmental stages and in other critical brain re-
gions.  
SSRI Exposure 
  There have been no investigations of the effects of   
prenatal SSRI exposure on 5-HT3 expression or function at 
any age.  
8. Summary of the effects of PC or SSRI Exposure on 
Serotonergic Signaling 
  There are many areas of investigation where no direct 
comparisons have yet been made between PC and prenatal 
SSRI exposure, or where particular developmental stages or 
sex differences have not yet been analyzed (see Table 2). 
Some effects of PC exposure may be dependent on SERT 
blockade, since prenatal SSRIs mimic these effects, while 
others seem to require additional mechanistic actions of   
cocaine. It is clear, however, that PC exposure extensively 
affects serotonergic signaling, with disruptions in growth 
factors, 5-HT levels, projections, metabolism, transport   
and several 5-HT receptor subtypes. There are many 5-HT 
receptor subtypes that have not yet been investigated follow-
ing PC exposure, including 5-HT1B, 5-HT1C, 5-HT1D, 5-
HT2B, 5-HT2C, 5-HT4 and 5-HT7. Although we may expect 
prenatal drug exposure to alter the regulation of these recep-
tors, this may not be the case since 5-HT receptor genes are 
differentially regulated by a variety of cellular mechanisms 
[126].  
  One major discrepancy between the preclinical and clini-
cal data is the age of subjects. Preclinical studies have fo-
cused primarily on adolescent and adults, with very few hav-
ing studied infant or juvenile development. The juvenile pe-
riod represents an area of investigation that warrants com-
prehensive studies of serotonergic signaling, since many 
behavioral effects are observed during this time frame. Con-
versely, clinical studies have has thus far only investigated 
infants and children, although it is reasonable to assume that 
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adolescence and early adulthood. From the preclinical litera-
ture it is clear that clinical studies of adult function should be 
performed in the future.  
  Of particular note, studies of infant hypothalamic sero-
tonergic signaling are absent and could be informative. Such 
studies will be critical to understanding the full impact of PC 
exposure on serotonergic signaling. Additionally, surpris-
ingly little work has assessed the effect of PC or prenatal 
SSRI exposure on serotonergic signaling or function within 
the brainstem, where 5-HT neurons are located. A well-
designed quantitative study of raphe 5-HT neurons would 
greatly enhance our understanding of serotonergic develop-
ment following PC or prenatal SSRI exposures. Transcrip-
tion factors such as SHH, GATA3, PET1, MASH1 are criti-
cal to the development and differentiation of these 5-HT 
neurons [127,128]. PC exposure does not affect SHH expres-
sion in the brainstem at the time when 5-HT neurons origi-
nate and begin to develop, suggesting that the origin and 
early differentiation of these neurons are likely unperturbed 
[129]. However, further investigation of the effects of PC 
and prenatal SSRI exposure on developing 5-HT neurons, as 
well as other important transcription and growth factors, are 
needed to determine whether, in fact, 5-HT neurons are in-
deed unaffected. 
  Although researchers have focused on various aspects of 
serotonergic signaling in the studies reviewed here, it should 
be noted that serotonergic signaling pathways are highly 
interactive with each other and with other neurotransmitter 
systems during development, such that direct effects of co-
caine may have indirect effects on other downstream targets. 
This is especially evident in the interactions between 5-HT, 
5-HT1A and SERT, as decreased function of one component, 
like those observed following PC exposure, can have long 
lasting effects others [52,130,131]. For example, SERT hy-
pomorphs exhibit reduced adult 5-HT1A signaling, an effect 
mimicked by PC exposure in males, which exhibit reduced 
SERT during infancy [50,85,130]. However, the absence of 
SERT throughout development decreases 5-HT1A differen-
tially in males and females [38]. Additionally, 5-HT1A 
knockout mice show reduced SERT binding in the cortex, 
hippocampus and striatum as adults [132], suggesting that 
the low 5-HT1A  receptor binding observed in PC exposed 
female infants may predict decreased SERT expression or 
function in adulthood. Future studies should consider these 
possible developmental compensations when interpreting the 
impact of PC and prenatal SSRI exposure.  
C. BEHAVIORAL CONSEQUENCES OF PRENATAL 
DRUG EXPOSURE 
  There is an abundance of literature documenting behav-
ioral changes following PC exposure, which has been the 
subject of several earlier reviews [133-136]. Disruptions in 
serotonergic signaling have been tied to developmental dis-
orders such as autism [63,137], and PC exposed children 
share many behavioral phenotypes with children with autism 
spectrum disorders, including attention deficits, aggression 
and impaired social behavior, and compromised communica-
tion skills [138]. It is critical to understand the functional 
relevance of changes following PC exposure in children and 
adults who may suffer from neurobiological disruptions. 
Since 5-HT is associated with the regulation of numerous 
behaviors, behavioral changes associated with PC and SSRI 
exposure that may be related to functional changes in the 
serotonergic system are summarized below. 
1. Attention Problems 
  Consistently occurring behavioral problems that have 
emerged from studies on PC exposure are attention/arousal 
deficits that are evident throughout development [139,140]. 
Attention in infants is typically measured by monitoring eye-
gaze and corresponding heart rate changes during specific 
stimuli presentation [141,142]. Attention-deficit hyperactiv-
ity disorder (ADHD) is clinically defined by exhibiting inat-
tention (difficulty sustaining attention and mental effort, for-
getfulness, and distractibility); hyperactivity (fidgeting, ex-
cessive talking, and restlessness); and impulsivity (difficulty 
waiting one’s turn and frequent interruption of others) [143]. 
Preclinical models investigating the impact of PC and prena-
tal SSRI exposure on attention have primarily used the spon-
taneous alteration test as a measure of working memory and 
attention; although, the testing protocol, age of the test sub-
ject, and motivational factors can play important roles in the 
interpretation of this task [144]. 
1.1. Infancy and Childhood 
PC Exposure 
  Infants and young children through primary school with 
PC exposure display decreased regulation of arousal-
mediated attention and behavioral state [142,145-148]. PC 
exposed children and adolescents, particularly males, have a 
higher incidence of developing ADHD [133,149]. Along 
with attention deficits, these children have other difficulties 
at school, such as abnormal externalizing behavior (e.g., act-
ing negatively on the external environment) and oppositional 
defiant disorder (e.g. not cooperating with authority figures) 
associated with their ADHD [140,149,150]. Recent neuroi-
maging data suggest that PC exposed adolescents exhibit 
differential activation of attention/arousal regulation cir-
cuitry, including working memory neurocircuitry (specifi-
cally prefrontal cortex and amygdala), in response to dis-
tracting emotional stimuli when compared to non-PC ex-
posed adolescents [151,152]. Although very little work has 
been done using animal models for this age, PC exposure 
(GD 4-18; 10 mg/kg/day) was found to cause significant 
differences in spontaneous alteration tests ( a measure of 
working memory and attention) in male and female adoles-
cent rats [153]. However, a higher dose of PC exposure (GD 
1-20; 30 mg/kg/day) had no effect on spontaneous alterna-
tion at PND 30 [154]. 
SSRI Exposure 
  Prenatal exposure to antidepressants (fluoxetine, paroxet-
ine, sertraline) results in tremulousness, decreased arousal, 
sleep disturbances and differences in behavioral state regula-
tion in newborns [155], but do not appear to affect mental 
development, attention, or impulsivity in young children 
[26,27,156]. In rodents exposed to fluoxetine at any dose (2-
12 mg/kg/day) from GD 7-20, no effect was observed during 
the juvenile or adolescent periods on spontaneous alterna-
tion, a test of working memory [157]. However, prenatal 
exposure to bupropion, an antidepressant more selective for 
the dopamine transporter, did increase likelihood to develop 
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1.2. Adulthood  
PC Exposure 
  PC exposure during the last 2 weeks of gestation (1-6 
mg/kg/day) results in decreased selective attention in adult 
male, but not female rats [158-160] with the exception of 
aged female rats who do exhibit attention deficits [161]. In-
terestingly, similar to adolescents, adult male rats with PC 
exposure (GD 1-20; 30 mg/kg/day) show no differences in 
spontaneous alteration [154]. Studies in clinical populations 
of PC exposed adults are sparse, but childhood ADHD   
has been associated with adult ADHD, anti-social behavior 
and aggression [162,163], and therefore it will be important 
to continue to monitor the mental health of PC exposed   
children diagnosed with ADHD. 
SSRI Exposure 
  Similar to juvenile and adolescent rats exposed to 
fluoxetine at any dose (2-12 mg/kg/day) from GD 7-20, there 
was no effect during adulthood on spontaneous alternation 
[157]. Data has not been reported in clinical populations of 
prenatally SSRI-exposed adults. However, such data should 
be collected to determine if problems develop with age. 
1.3. Serotonergic Effects May Underlie Attention Deficits 
  The role of serotonergic function in attention has been 
studied extensively [164]. Postsynaptic 5-HT receptors in the 
prefrontal cortex are thought to play an important role [165]. 
Recent evidence also suggests a role for presynaptic 5-HT 
receptors in some of the symptoms associated with ADHD 
[166]. The 5-HT1A receptor is a likely candidate for this tar-
geted effect, since it is expressed in the attention-regulation 
region of the superior colliculus and is known to be ex-
pressed presynaptically [34,112,167]. 5-HT and DA interac-
tions play important roles in regulating attention processing 
in several brain regions [164,165,168]. ADHD has been 
linked to changes in DA receptor signaling [169], and PC 
exposure is associated with attention deficits mediated by 
DA and NE signaling pathways [139,170]. In addition, diffi-
culties in attention regulation are often co-morbid with be-
havioral problems in aggression or depression [162,171], 
both of which involve serotonergic signaling and are   
disrupted by PC exposure (See Section C. 2. Anxiety and 
Depressive-Like Behavior and Section C.5 Aggression). 
  These data suggest that attention deficits following PC 
exposure may not be related solely to SERT blockade, but 
may also occur through the dopaminergic system, mediated 
by either blockade of the dopamine transporter (DAT) and/or 
SERT [39], or by effects on dopamine release caused by 
changes in serotonergic signaling at presynaptic 5-HT1A re-
ceptors [172]. PC exposure appears to impact 5-HT1A recep-
tors, specifically decreasing 5-HT1A in both the raphe nuclei 
and frontal cortex of male rats [50], suggesting a possible 
mechanism of action for attention problems in PC exposed 
males. Thus, 5-HT1A receptor ligands might be useful tools 
to use with attention deficits resulting from PC exposure. 
Although these are important first steps in investigating how 
prenatal SERT blockade may contribute to attention prob-
lems, further work is necessary to fully conclude that nega-
tive consequences follow prenatal exposure and to investi-
gate potential mechanisms. 
2. Anxiety and Depressive-Like Behavior 
  Mood disruptions including anxiety and depression are 
clinically defined by physicians following personal inter-
views and specialized questionnaires such as the Hamilton 
Rating Scale for Depression (HAM-D) or Anxiety (HAM-A) 
[173,174]. Consistent and reliable tests have been developed 
to assess anxiety and depressive-like behavior in rodent 
models. These include the elevated plus maze, open field 
test, light-dark box and social interaction for anxiety 
[175,176]. Measuring a depressive-like state in the rodent is 
routinely studied using a forced swim test, tail suspension 
test for assessing a “despair” phenotype, or by measuring the 
animal’s motivation for hedonic stimuli [177]. Unfortu-
nately, there are no validated tests for anxiety or depressive-
like behavior in rodent infants (younger than PND10), since 
ultrasonic vocalizations (USVs) have been suggested to   
be largely a function of thermogenesis regulation and not 
anxiety in infant rats at this early age [178,179], although 
these are communicative sounds and will be discussed later  
(see Section C.7. Language and Communicative Ability). 
However, in juvenile rats and mice, separation-induced 
USVs are commonly used as a marker for anxiety, given that 
they can be decreased by anxiolytics [180,181]. 
2.1. Infancy and the Juvenile Period  
PC Exposure 
  Little is known about the impact of PC exposure on the 
development of anxiety or depressive behavior during in-
fancy or childhood in humans. Given that PC exposure in-
creases the likelihood of developing ADHD and aggression, 
and that these behavioral problems are often co-morbid with 
mood disorders, future clinical studies should measure anxi-
ety in children following PC exposure [162,163,182]. Sev-
eral recent preliminary studies have found altered USVs 
from PC exposed rats at PND 14 [183,184]. Following PC 
exposure (GD 1-20; 30 mg/kg/day), both male and female 
juvenile rats have been shown to exhibit enhanced anxiety-
like behavior in the open field [185,186]. The same treatment 
paradigm also results in neophobia (as measured by hypoac-
tivity in a novel environment compared to controls) between 
PND 20 and 35 [153,187,188]. Interestingly, intermittent PC 
exposure (30 mg/kg/day) throughout pregnancy, to model 
the “weekend user,” showed no effects on locomotor activity 
or anxiety-like behavior [187], indicating that amount and 
frequency of exposure may be important variables. 
SSRI Exposure 
  Children exposed to antidepressants (fluoxetine, paroxet-
ine, or sertraline) do not show major differences in anxiety or 
depressive symptoms according to the Child Behavior 
Checklist [189]. Male and female juvenile mice show in-
creased separation-induced USVs following full gestational 
exposure to the SSRI paroxetine (30 mg/kg/day), suggesting 
increased anxiety [190]. Several studies have shown that 
treatment with either paroxetine or fluoxetine does not   
affect elevated plus maze behavior (anxiety-like behavior), 
forced swim (depressive-like behavior) or general locomotor 
activity in male adolescent mice or rats [25,28,157,190]. In 
male rats, prenatal exposure to the less specific SRI, 
chloripramine (GD 8-21; 3 or 10 mg/kg/day), results in an 
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but an anxiogenic effect as measured by the open field test 
[191]. Following pre- and early postnatal fluoxetine expo-
sure (GD 1-PND 14; 7.5 mg/kg/day), adolescent female mice 
exhibit increased depressive-like behavior in the forced swim 
test [25], suggesting that females are more sensitive to SSRI 
exposure.  
2.2. Adulthood  
PC Exposure 
  Adult male and female PC exposed (GD 1-20; 30 
mg/kg/day) rats exhibit increased depressive-like behavior 
when tested at PND 60 and 120, while exposure to a higher 
dose (GD 8-20; 40 mg/kg/day) results in expression of de-
pressive-like behavior in adults for up to 12 months [192]. 
The literature concerning anxiety-like behavior in rodents is 
less clear. PC exposure (GD 8-20; 30 mg/kg/day) increases 
anxiety-like behavior in the elevated plus maze and the open 
field test at PND 60, with continued increases up to one year 
in male and female rats [161,192,193]. In contrast, PC expo-
sure (GD 1-20; 30 mg/kg/day), either chronic or intermittent, 
only has a minor impact on anxiety-like behavior as meas-
ured by elevated plus maze, open field or social interaction at 
PND 60 in males or females. However, severe neophobia 
was observed at this age, which was more pronounced fol-
lowing chronic PC exposure compared to intermittent PC 
exposure [154,185,187]. By PND 90, a trend towards neo-
phobia was still observed, with no other effects in males, 
although females showed slightly less anxiety on the ele-
vated plus maze [153,154]. By PND 120, anxiety returned in 
males, as measured by social interaction, but not elevated 
plus maze [185]. In contrast, following intermittent PC expo-
sure, only males showed hyperactivity in the open field 
[154]. Taken together, these results suggest that PC exposure 
can affect anxiety-like behavior depending on sex and age of 
testing. A future focus on these behaviors in human popula-
tions might prove useful, since anxiety is highly correlated 
with ADHD [194], and such children are at high risk for this 
disorder, as discussed above.  
SSRI Exposure 
  Fewer studies have investigated the effects of prenatal 
SSRI exposure on later emotional regulation. Similar to ado-
lescents, adult male mice show no effect of prenatal paroxet-
ine (GD 1-21; 30 mg/kg/day) treatment on anxiety or depres-
sive-like behavior [190], while exposure to fluoxetine (GD 
1-PND14; 7.5 mg/kg/day) increases depressive-like behavior 
in female, but not male mice [25]. Prenatal exposure to   
the less specific SRI, chloripramine (GD 8-21; 3 or 10 
mg/kg/day) had no effect on anxiety, as measured by the 
social interaction test or open field test, in male rats [191]. 
These data suggest that females may be more susceptible to 
the effects of prenatal SSRI exposure on emotional behavior 
throughout development. 
2.3. Serotonergic Signaling Involvement in Anxiety and 
Depression 
  Anxiety and depression are correlated with 5-HT   
levels, SERT, 5-HT1A, and 5-HT3 receptor activity 
[80,122,195,196], all of which are also disrupted in PC ex-
posed male offspring. Serotonergic changes may underlie 
differences in depressive-like behavior observed in both 
male and female PC exposed offspring. This could be di-
rectly tested using pharmacologic methods to determine sys-
temic changes that result in specific behavioral effects. 
Anxiety and depressive behavior have also been strongly tied 
to stress reactivity [197,198]. Therefore, it is possible that 
these behaviors are related to alterations in stress response 
systems that are often seen in PC exposed offspring (see   
Sections C.3. and C.4 Hormonal and Behavioral Stress 
Response). These results suggest that females are especially 
sensitive to prenatal SSRI exposure compared to males, al-
though differences in SERT expression or activity, which 
may be expected with differences in depressive behavior, 
have not been investigated in females. Future preclinical 
studies could investigate the impact of prenatal SSRIs on 
female 5-HT levels and terminals, which might also be in-
volved in increased depressive behavior in females. Evi-
dence suggests that prenatal SERT blockade may be suffi-
cient to cause changes in female behavior, while other 
mechanisms of cocaine action may be more critical for ef-
fects on male behavior and neuronal function. However, 
blockade of the DAT alone may not be sufficient to cause 
changes in male behavior, since studies with prenatal expo-
sure to amfonelic acid (AFA), a drug that blocks the DAT, 
causes only minor changes in spontaneous activity but not 
anxiety-like behavior, at least during adolescence [154,187]. 
AFA exposure did result in hypoactivity, and a tendency to 
exhibit neophobia by PND 60, but not PND 180, in males 
[154,187]. The antidepressant, bupropion (primarily a DA 
transporter blocker, with greater affinity for SERT than 
AFA; see Table 1), can cause increased anxiety in adult male 
mice [199] similar to that observed with PC exposure, sug-
gesting that disruptions in these signaling systems are com-
plex, but still potentially important for the development of 
anxiety. 
3. Hormonal Stress Response 
  Response to physiological or psychological stressors in-
volves activation of the hypothalamic-pituitary-adrenal 
(HPA) axis to release corticotrophin releasing factor (CRF), 
adrenocorticotrophic hormone (ACTH) and cortisol (corti-
costerone in rodents or CORT). Typically, this response   
begins immediately and causes hormone levels to peak five 
to 10 minutes after the stimulus, followed by a return to 
baseline levels within an hour. Although it is extremely 
adaptive to exhibit a hormonal stress response, higher levels 
for longer periods of time in a test group indicate differences 
in stress perception, and can have long-lasting effects on 
physiology [200]. Importantly, CRF is released from the 
paraventricular nucleus (PVN) of the hypothalamus, and acts 
as a hormone in the bloodstream and as a neurotransmitter 
throughout the CNS, including the limbic system, providing 
an avenue for stress signaling to interact with other behav-
iors, including anxiety, depression and aggression [197,201]. 
Although hormonal and behavioral stress responses are gen-
erally congruent, it has been shown that CRF can act in the 
forebrain to produce a behavioral response independent of a 
hormonal response, suggesting that regional expression of 
CRF is critical for appropriate integrated responding [202]. 
One important aspect of PC exposure that has been noted is a 
differential response to stressful stimuli in males and females 
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3.1. Infancy and the Juvenile Period  
PC Exposure 
  Studies in human PC exposed infants indicate that age of 
testing is important for interpreting results. One study found 
that PC exposed infants show no difference in basal CORT 
and lower CORT in response to both invasive and non-
invasive procedures at 2 months [204], whereas another 
study found lower basal CORT levels but no difference in 
response to a pin prick 13-months [205]. Recently in PC 
exposed 11 year olds, blunted CORT response to a psycho-
logical stressor was observed, with no differences in baseline 
CORT, mimicking the results of the 2-month old study 
[206]. These results suggest either a developmental compen-
satory response or a reaction to the hormonal milieu. These 
changes may also interact with the early life environment 
(See Section D. 1.1 Maternal Drug Use Disrupts Maternal-
Infant Interactions). PC exposed (GD 8-20; 40 mg/kg/day) 
rats exhibit higher CORT and ACTH levels, with corre-
spondingly higher c-FOS expression in the PVN of the hypo-
thalamus (where CRF is produced) in response to acute and 
repeated foot shock-induced stress, when tested as juveniles 
[207]. Basal levels of ACTH and CORT are unchanged dur-
ing adolescence in PC exposed (GD 13-20; 30 mg/kg/day) 
animals, although males have an increased ACTH response 
to 5-HT receptor agonists, while females have a diminished 
response compared to controls [24,112,208]. Additionally, at 
PND 30, PC exposed (GD 1-20; 30 mg/kg/day) male rats 
show an extended and greater rise in ACTH and CORT to 
restraint stress [209]. These results suggest that regardless of 
exposure length, males have increased HPA activity follow-
ing PC exposure.  
SSRI Exposure 
  Less is known regarding the effects of prenatal exposure 
to SSRIs on the hormonal stress response in humans. A re-
cent study found that human infants prenatally exposed to 
SSRIs (fluoxetine, paroxetine, sertraline, citalopram, or ven-
lafaxine) had reduced basal CORT levels, and although in 
control infants, breast-feeding infants differed from bottle-
feeding infants in their basal CORT levels, SSRI exposed 
infants did not differ based on feeding type [173]. These data 
suggest that these infants may be less responsive to neonatal 
environments.  
3.2. Adulthood 
PC Exposure 
  In preclinical studies of PC exposure, basal levels of 
stress hormones do not differ from controls at adulthood 
[112,209]. However, several studies have obtained disparate 
results regarding the impact on the HPA axis in response to 
stressful stimuli; while some studies (GD 8-17: 20; 40 
mg/kg/day) found no change [210], others found an in-
creased [209,211] or decreased response [186]. Specifically, 
PC exposed (GD 1-20; 30 mg/kg/day) males show lower 
ACTH, but not CORT 90 min after an elevated plus maze 
and following exposure to a stranger male, although females 
show no difference due to PC exposure [186]. These con-
flicting results, suggesting either increased reactivity follow-
ing PC exposure or an inappropriately blunted response, 
probably depend on the type of stressor, timing of hormonal 
assay, hormones measured, and extent of PC exposure.  
SSRI Exposure 
  We could find no studies investigating stress reactivity at 
later time points in either clinical or preclinical models. This 
will be an important area for future study, not only to under-
stand long term effects of prenatal SSRI exposure on stress 
reactivity, but also for understanding the role SERT blockade 
plays in mediating the consequences of PC exposure. 
3.3. Changes in Serotonergic Signaling May Underlie 
Stress Responsiveness 
  The important interactions between canonical stress hor-
mones and serotonergic signaling may be central to under-
standing some of the hormonal effects observed following 
PC exposure. CRF interacts with serotonergic mechanisms in 
several ways [212]. 5-HT1A activity in both the raphe nuclei 
and the PVN can drive ACTH secretion, suggesting an indi-
rect increase in CRF activity [213]. Alternatively, SERT 
activity can block CRF-induced behavioral responses [214]. 
Given that 5-HT1A-induced release of ACTH is increased in 
PC exposed males, but not females, this effect may be func-
tionally related to male-specific changes. The potential im-
portance of 5-HT1A receptors in male responsivity is 
strengthened by lack of evidence for changes in SERT activ-
ity in adulthood following PC exposure (See Section B.4.3 
Developmental Effects on Serotonin Reuptake Sites). CRF 
expression and activity following PC exposure has yet to be 
measured, but would be highly informative, since it: 1) can 
drive the observed ACTH changes; 2) can play a critical role 
in stress reactive behaviors (anxiety and depression); and 3) 
is active in brain regions where decreases in 5-HT1A recep-
tors may play important roles [50,198,208]. Differences in 
regional CRF expression may potentially explain sex differ-
ences in behavioral stress response and anxiety observed 
following PC exposure. Future studies that focus on devel-
opmental differences in CRF activity or receptor expression 
following PC exposure to determine if they correspond with 
changes in serotonergic signaling, as well as directly test 
involvement of the HPA regulatory feedback system to   
determine the exact deficits responsible for the observed 
behavioral changes in stress response, would be useful. 
4. Behavioral Stress Response 
  Behavioral stress response is commonly defined as any 
behavior exhibited immediately following the presence of 
stressful stimuli. Stressful stimuli are either inferred by the 
investigator or have been previously shown to increase hor-
monal stress levels. In children and adults, this may include 
crying, facial expressions of displeasure and signs of irrita-
bility. In animal models, changes in locomotor activity (in-
cluding freezing), ability to habituate to novel or fearful en-
vironments and expression of USVs are also interpreted as 
behavioral responses to stress. Additionally, neuronal activa-
tion studies have begun to determine brain circuitry activity 
that may inform the literature about the perception of these 
stimuli. 
4.1. Infancy and Childhood 
PC Exposure 
  PC exposed human 7 month old infant boys and girls 
exhibit a decreased latency to anger during an infant restraint 
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greater arousal to a frustrating task compared to non-exposed 
children, with males being particularly sensitive to the test, 
as indicated by increased requests for the caregiver [216]. 
This is especially interesting given that another study found 
PC exposed toddlers showed less negative reactivity to sepa-
ration from their mothers, typically considered a stressful 
event [217]. PC exposed children at age 5 continue to exhibit 
a decreased latency to frustration, with males showing the 
strongest effect [218]. Following PC exposure (GD 8-20; 40 
mg/kg/day), juvenile male rats exhibit shock-induced hyper-
activity and less wall-climbing, indicating a direct response 
to the stressful environment [219]. Following the same   
PC exposure, juvenile male, but not female, rats retain the 
habituated orientation response longer than controls, suggest-
ing that they react differently to this stressful environment 
[220].  
SSRI Exposure 
  Very little work has been done to study the effects of 
prenatal SSRI exposure on behavioral stress response in 
young children. However, one study has shown children be-
tween 15 and 30 months who were prenatally exposed to 
fluoxetine or tricyclic antidepressants do not show any dif-
ferences in temperament or other stress responsive behaviors 
[221]. Externalizing behaviors (acting negatively on the en-
vironment) do not seem to be increased by prenatal SSRI 
exposure, but instead depend on maternal depression [26]. 
These data suggest that prenatal SSRI exposure does not 
negatively affect behavioral stress response in infants or 
young children, however, more specific testing should be 
performed before final conclusions are drawn. 
4.2. Adolescence  
PC Exposure 
  In one study, both male and female adolescent rats 
showed less habituation to a repeated stressor following   
PC exposure (GD 8-21; 40 mg/kg/day) [222]. Although 
amygdala neuronal activation to footshock seemed un-
changed, cortical response was increased in adolescent PC 
exposed (GD 10-20; 6 mg/kg/day) male rats, suggesting an 
altered perception of a normally stressful stimulus. Unfortu-
nately, females were not tested in this study [223].  
SSRI Exposure 
  There are not yet any studies investigating the affect of 
prenatal SSRIs on adolescent behavioral stress response. 
4.3. Adulthood  
PC Exposure 
  Male rats with high-dose PC exposure (GD 8-20; 80 
mg/kg/day) show greater struggling during a forced swim 
test, which has been interpreted as difficulty coping with a 
stressful situation [224]. Mice with PC exposure (GD 9-17; 
20 and 40 mg/kg/day) exhibit a shorter latency to freeze fol-
lowing footshock [210]. Similarly, rats with lower-dose PC 
exposure (GD 8-20; 40mg/day) showed less behavioral adap-
tation to a stressful footshock [225,226], with increased cor-
tical response but unchanged amygdala neuronal activation 
[223], suggesting that additional circuitry may have been 
activated and that pain perception is very different in these 
animals. PC exposed female rats (GD 1-20; 30 mg/kg/day) 
produced more USVs compared to controls in response to an 
air puff at PND 180, again indicating that there is a differ-
ence in stress response to sensory stimuli [227]. 
SSRI Exposure 
  Although the literature on behavioral stress response fol-
lowing prenatal SSRI exposure is sparse, a few recent studies 
have shown that prenatal exposure to the antidepressant 
bupropion (a NE and DA transport blocker; GD1-20; 25 
mg/kg/day), but not citalopram (GD1-20; 5 mg/kg/day), a 
SSRI, causes increased stress susceptibility (as measured by 
anxiety and vulnerability to drug seeking) in adult male mice 
[199,228]. These data suggest that prenatal SERT inhibition 
may not be the primary factor in disrupting stress reactivity. 
4.4. Changes in Serotonin may Underlie Changes in   
Behavioral Stress Response 
  Certain changes in infant behavior following PC expo-
sure are similar to those observed with 5-HT syndrome, in-
cluding tremulousness, restlessness and well-documented 
effects on sleep [153,229-231], although no studies have 
been performed to assess this connection directly. However, 
PC exposure causes sex-specific changes in 5-HT1A recep-
tors in the hindbrain (see Section B. 5. 5-HT1A Receptors), 
which are believed to contribute to the behavioral symptoms 
of 5-HT syndrome [69], suggesting that hindbrain 5-HT sig-
naling may underlie some neonatal behavioral differences 
and indicating future studies should include investigations of 
sex differences in neonates. 
  These data suggest that, although further work is needed, 
prenatal SERT blockade alone may not be enough to cause 
changes in behavioral stress response, since there are many 
more effects observed in PC exposed children and offspring. 
Behavioral response to stress relies on mood state (anxiety 
and depression) and learning from previous experiences 
(such as aggressive interactions). Since these other behav-
ioral changes are more greatly affected by PC exposure 
compared to SSRI exposure, they may contribute to the se-
verity of changes in behavioral stress response observed thus 
far. Alternatively, fewer studies have been performed to ex-
amine this arena, especially in females, and such studies 
would be greatly informative.  
5. Aggression 
  Aggression is broadly defined as any action meant to 
cause harm to another individual, usually preceded by a con-
flict, although initiation of conflict is also considered aggres-
sive. Studies of human aggression typically operationally 
define the definition, although are commonly divided into 
instrumental and reactive aggression [232]. Both, however, 
commonly measure violence, hostility and retaliation [233]. 
Instrumental aggression is a goal-driven action, while reac-
tive aggression is a response to the current environment 
[232]. Childhood aggression is typically reported using the 
Childhood Behavior Checklist [233]. Instrumental aggres-
sion is not commonly observed in young children but in-
creases during adolescence, while reactive aggression can be 
observed earlier [232]. Aggressive behaviors in rodents fall 
into 2 major categories: offensive and defensive. Offensive 
behaviors are analogous to instrumental aggression in hu-
mans, serving primarily to obtain resources. Defensive be-
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ing to protect one’s self, young or territory from harm 
[232,234]. 
5.1. Childhood and Adolescence 
PC Exposure 
  In human children, it has been noted that PC exposure is 
correlated with increased aggressiveness in males, an effect 
that has not yet been observed in females [235,236]. Studies 
targeting aggression in older children and adolescents are not 
yet available, as they are currently being tracked. Hopefully, 
future studies will reveal the longer-term impact of PC expo-
sure on aggressive behavior in humans, especially since ex-
ternalizing behavior, more common in PC exposed children 
[149], is associated with aggression in adulthood [237]. PC 
exposed (GD 8-20; 40 mg/kg/day) juvenile rats have a lower 
latency, but a shorter duration, of nipple attachment during a 
nipple competition task, a test for early social dominance 
[238]. Similar PC exposure results in adolescent males, but 
not females, which are significantly more aggressive in a 
social competition for water following water deprivation 
[238]. However, following the same PC exposure (40 mg/kg; 
GD 8-20), adolescent males were no different or performed 
fewer pouncing or pinning behaviors compared to controls 
during a play behavior task, although females were not 
measured in this study [222]. These results suggest an inter-
action of stress on aggressive behavior, since the aggression 
is more notable following the stress of overnight water dep-
rivation. 
SSRI Exposure 
  There are, as yet, no clinical studies regarding effects of 
prenatal SSRI exposure on aggressive behavior, although 
given the prevalence of aggressive disorders in PC exposure 
and the impact prenatal SSRIs have on adult aggression (see 
Section C. 5.2.), children prenatally exposed to SSRIs 
should be monitored closely.  
5.2. Adulthood  
PC Exposure 
  PC exposure (GD 13-20; 25 mg/kg/day) increases ag-
gression in adult mice [239]. Similarly, adult male PC ex-
posed (GD 8-20; 40 mg/kg; GD 8-20) rats show increased 
aggression in a water competition task [238]. Not surpris-
ingly, longer PC exposure (GD 1-20; 30mg/kg/day) result in 
males that are more aggressive and defensive in early and 
later adulthood to intruder males [154,186]. Additionally, 
intermittent PC exposure (GD 1-20; 30/mg/ day every fifth 
day) also results in increased aggressive behavior towards an 
intruder male [240]. PC exposed males also fail to show the 
decrease in defensive behavior observed in controls follow-
ing a geprione (5-HT1A agonist) injection [240]. Interest-
ingly, PC exposed females (GD 1-20; 30 mg/kg/day) also 
exhibit increased aggression in both social interactions with 
other females [186], and maternal aggression directed at in-
truder males, indicating effects that are maintained through 
adulthood and through the major hormonal changes associ-
ated with pregnancy and lactation [21]. 
SSRI Exposure 
  Animal studies that have investigated how prenatal   
SSRI exposure impacts aggression have shown increases in 
aggression similar to those observed following PC exposure. 
Chronic prenatal SSRI exposure to either fluoxetine (GD 1-
PND 14; 7 mg/kg/day and GD 13-21; 10 mg/kg/day) or par-
oxetine (GD 0-21; 30 mg/kg/day) increases aggressive be-
havior in adult male mice and rats without changing this be-
havior in females [25,190,241], suggesting that fetal SERT 
inhibition may differentially impact male and female aggres-
sive behavior. Rats with prenatal AFA exposure have shown 
increased aggressive behavior compared to controls follow-
ing a 5-HT1A agonist, gepirone, but not under basal condi-
tions [240]. Future studies should examine earlier time points 
and different prenatal exposure paradigms to confirm the 
role of SERT inhibition in the development of increased 
male aggressive behavior.  
5.3. Changes in Serotonergic Signaling May Underlie   
Increased Aggression 
  Changes in serotonergic signaling resulting from PC ex-
posure may underlie some of the changes in aggressive be-
havior discussed above. Increased serotonergic tone has an 
overall inhibitory effect on aggression in preclinical studies 
[242,243]. A recent review of these studies highlights impor-
tant factors to be considered, including: the species and 
strain of rodent utilized, which impacts genetic predisposi-
tion; and different treatment paradigms of serotonergic ma-
nipulations, given the importance of the dynamic interplay of 
serotonergic signaling systems in aggressive behaviors [244]. 
PC exposure in rodents results in lower basal 5-HT, dis-
rupted 5-HT1A and SERT activity, and increased 5-HT3 ac-
tivity, all of which could lead to more impulsive or aggres-
sive behavior in offspring (see Figs. 3 and 4). Specifically, 
low basal levels of 5-HT are correlated with increased   
aggression [79], an effect that is observed in many brain   
regions in PC exposure animal models in both males and 
females (See Section B.2. Serotonin Levels and Neuronal 
Growth Throughout Life). 5-HT3 activity, particularly in 
the prefrontal cortex, nucleus accumbens and medial 
amygdala, has been positively associated with aggression 
[124,245], and increased 5-HT3 activity in the striatum has 
been observed in PC exposed mice [107,125]. Although   
both adult male and female rats show increased aggression 
following PC exposure, these behavioral changes may be 
accounted for by different mechanisms. 
  Importantly, with respect to the results discussed above, 
stimulation of frontal cortical 5-HT1A receptors acutely re-
duces aggression. Consistent with this, PC exposed male rats 
have lower 5-HT1A binding, suggesting lower basal 5-HT1A 
activity [95,113,246-248]. Moreover, PC exposed males are 
less sensitive to geprione to decrease defensive behaviors, 
suggesting that 5-HT1A receptors are less able to regulate 
aggressive interactions in PC exposed males [240]. Addi-
tionally, testosterone has been shown to interact with 5-HT1A 
receptors during the neonatal period to influence offensive 
and defensive behavior in adults [111], and PC exposed 
males have increased 5-HT1A  receptors  at this time (See   
Fig. 3), possibly potentiating this effect.  
  Alternatively, PC exposed females, have increased 5-
HT1A receptor binding specifically in the forebrain during 
adulthood (See Fig. 2), a time point when aggression is in-
creased (See Section C.5.2 Aggression) [21]. These findings 
mirror results in hamsters bred for highly aggressive behav-496    Current Neuropharmacology, 2011, Vol. 9, No. 3  Williams et al. 
ior which have higher numbers of 5-HT1A receptors in the 
anterior hypothalamus, lateral septum, nucleus accumbens 
and prefrontal cortex [124]. This is consistent with the fact 
that in humans, increased 5-HT1A receptor binding in pre-
frontal cortex is correlated with higher aggressive behavior 
[246], illustrating the importance of regional localization of 
these receptors for their role in aggression and sex-specific 
differences in serotonergic regulation of aggression.  
  It is important to note that increased 5-HT1A receptor 
activity has been directly related to decreased 5-HT release 
[34,249-251] in rat models, which may explain the lower   
5-HT levels seen in PC exposed rats (See Section B.2  
Serotonin Levels and Neuronal Growth Throughout 
Life). However, immunobinding data indicates fewer 5-HT1A 
receptors in the raphe nuclei in both adult males and females 
(see Fig. 2), suggesting that the activity of these receptors 
may have undergone compensatory functional changes to 
influence 5-HT levels or that changes in 5-HT1A receptor 
during infancy may have had long-lasting effects on 5-HT 
production. Future studies investigating the direct role   
of these changes in 5-HT signaling mechanisms and their 
role in aggression will be greatly informative. In addition, 
disrupted 5-HT release in conjunction with increased or   
altered 5-HT3 and/or 5-HT1A activity contribute to increased 
levels of aggressive behavior differently across developmen-
tal stages. Taken together, these findings raise the possibility 
of pharmacologic intervention with serotonergic drugs, 
which may prove useful in treatment of aggression in PC and 
prenatal SSRI exposed individuals.  
6. Social Behavior 
  Social behavior is broadly defined as any behavioral in-
teraction with another individual from the same species. In 
humans, social behavior necessitates some form of commu-
nication through either verbal or body language, including 
eye contact. We focus here on the positive social interac-
tions, excluding aggression, which are rewarding to humans 
and animals [252,253]. The study of social interaction in 
clinical and preclinical studies usually entails behavioral 
analysis of interaction including approach/avoidance, active 
investigation of individual, and the amount and type of 
physical contact [254]. During infancy, social interaction 
refers to behavioral episodes that are not specifically related 
to infant health and well-being. Social interactions increase 
in juvenile and adolescent humans and rodents, with selec-
tion for interaction with their own peer group, followed by a 
decline as adulthood is reached [253,255,256]. Understand-
ing social interaction includes studies that investigate brain 
structures involved in processing social information/cues and 
performing social interactions.  
6.1. Infancy and the Juvenile Period  
PC Exposure 
  Both male and female PC exposed human infants differ 
from non-exposed infants in their response to the Still-Face 
task, a measure of interpreting social cues [257], and young 
children with PC exposure have higher rates of autistic spec-
trum disorders and deficits in social and play interactions 
[258]. PC exposed toddlers show less reactivity to separation 
from their mothers [217]. Additionally, PC exposed children 
are less empathic and exhibit greater frontal cortical asym-
metric activity when shown a crying infant or their own 
mother [259], supporting the hypothesis that frontal cortex 
function is critical for such behavioral disruptions. PC ex-
posed children have a higher rate of oppositional defiant 
disorder, another indicator of misunderstanding appropriate 
social context [149]. PC exposed (GD 1-20; 30 mg/kg/day) 
infant rats are less capable of eliciting maternal care from 
normal rat mothers [260]. Social context can influence 
physiological response to stress (e.g., increased heart rate) in 
control juvenile rats, although in PC exposed (GD 8-20; 40 
mg/kg/day) animals this effect is not present, indicating that 
social context is perceived differently [261]. Therefore, it is 
important to repeat a similar study in PC exposed children to 
determine whether physiological differences in response to 
different social contexts are apparent.  
SSRI Exposure 
  The only study to date that has investigated gestational 
exposure to the SSRI paroxetine (GD1-21; 30 mg/kg/day) 
found no differences in juvenile male and female rat social 
play behavior [190].  
6.2. Adolescence  
PC Exposure 
  PC exposed (GD 1-20; 30 mg/kg/day) male and female 
rats spend less time interacting with novel rats at PND 30 
[185]. Furthermore, although both male and female adoles-
cent rats show no difference in initiated play behavior   
following PC exposure (GD 8-21; 40 mg/kg/day), they are 
less capable of eliciting social interaction from age-matched 
controls [222,262]. PC exposure (GD 1-20; 30 mg/kg/day) 
does not, however, have an effect on pup-induced maternal 
behaviors (concaveation) in early adolescent male or female 
rats [263], a task where there is no direct elicitation from  
the pups, suggesting that there may be something about PC 
exposed adolescent offspring that is aversive to their peers. 
Further studies should explore this developmental period, 
since it is critical for developing appropriate adult social 
interactions.  
SSRI Exposure 
  No studies have investigated later time points in devel-
opment with respect to social interactions following prenatal 
SSRI exposure. Future studies to determine whether prenatal 
SSRI exposure affects any of these behaviors would be in-
formative, given the numerous effects caused by PC expo-
sure and the increases in aggression noted after prenatal 
SSRI exposure (see Section C.5.1 Aggression). 
6.3. Adulthood  
PC Exposure 
  In adult PC exposed (GD 13-20; 25 mg/kg/day) mice, 
there are higher amounts of fleeing from and avoidance of 
novel mice [239]. Similarly, rats exposed throughout gesta-
tion (GD 1-20; 30 mg/kg/day) show decreased duration of 
social interaction with unfamiliar peer rats as adults, just as 
they do in adolescence [185]. PC exposed males take longer 
to reciprocate contact at PND 90, while females take longer 
to allow contact and are more likely to rough groom unfamil-
iar female rats [186]. PC exposed males also have blunted 
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an altered perception of the social environment [186]. PC 
exposure (GD 1-20; 30 mg/kg/day) disrupts later maternal 
behavior exhibited by female rats [260], but does not impact 
pup-induced male parental behavior in rats [263].These data 
suggest that such deficits can last throughout life, but further 
studies are needed to determine whether such effects can be 
generalized to both sexes or to the critical adolescent period. 
Given the high correlation between social disorders and 
ADHD in PC exposed children, clinical trials might focus on 
infant developmental studies, with close monitoring of pre-
natally exposed children for specific behavioral problems 
[147,264].  
SSRI Exposure 
  No studies have investigated later time points in   
development with respect to social interactions following 
prenatal SSRI exposure. Future studies to determine whether 
prenatal SSRI exposure affects any of these behaviors would 
be informative, given the numerous effects caused by PC 
exposure and the increases in aggression noted after prenatal 
SSRI exposure (see Section C. 5.2. Aggression). 
6.4. Changes in the Serotonergic System May Directly Im-
pact Social Behavioral Deficits 
  Serotonergic involvement in regulation of social interac-
tions remains largely unexplored. Given that low 5-HT levels 
in mice are associated with low sociability [265] and higher 
aggression [244], and that serotonergic signaling is thought 
to be disrupted in autism [137], it seems reasonable to hy-
pothesize there is a role for 5-HT in these behaviors. Addi-
tionally, social behaviors can be disrupted if there are co-
morbid problems with stress, depression or attention [266-
268], behavioral disorders that also occur at an increased 
frequency in PC exposed children (see Sections on C.1.   
Attention, C.2. Anxiety and Depressive-Like Behavior 
and C.3 and C.4 Stress Response). Of note, PC exposure 
has been linked to an increased likelihood of a diagnosis   
of autism spectrum disorder [258], along with decreasing 
CNS 5-HT levels (See Section B.2. Serotonin Levels and 
Neuronal Growth Throughout Life). Further work is 
needed to determine whether there is a direct relationship 
between serotonergic deficits and social behavior in PC ex-
posed individuals. Similarly, it is difficult to determine at 
this time whether SERT blockade plays an important role in 
the social behavior deficits observed following PC exposure 
since there is a paucity of data surrounding fetal SERT 
blockade and later social behaviors.  
7. Language and Communicative Ability 
  Another especially important aspect of social behavior is 
communication between individuals. Although a variety of 
ways to communicate exist, humans have the unique advan-
tage of language (verbal and visual) to express our thoughts 
and feelings. Language and its development is a well devel-
oped field of study too broad to cover here. Studies on lan-
guage development may focus on vocabulary and grammati-
cal structure, as well as the type of language typically used 
by an individual. Expressive language is the ability to pro-
duce language, while receptive language is the ability to un-
derstand language, and pragmatic language is the ability to 
integrate a variety of language cues and effectively use lan-
guage in a social environment [269]. Importantly, recent 
research has shown that the neural correlates of language 
may exist at birth, and that social interaction increases lan-
guage learning in infants [270]. Ultrasonic vocalizations 
(USVs) constitute one major method of communication for 
rodents, including pups [251,252]. Rodent models of vocal-
ized communication have proven useful for understanding 
social, emotional and stress responding in adults [263-266]. 
Therefore, understanding changes in rodent USVs may help 
us understand human language. 
7.1. Infancy and Childhood  
PC Exposure 
  PC exposure disrupts human newborn vocalizations 
[146], which are important signals to caregivers. PC expo-
sure results in well documented disruptions in language   
development in early childhood, especially expressive com-
pared to receptive language [135,258,271-275], although this 
is not always the case [276,277]. Differences in expressive 
versus receptive language abilities are dependent on age and 
sex [272,273], such that males are generally more greatly 
affected by PC exposure. Future studies should continue to 
investigate whether these problems persist throughout adult-
hood. Differences in the ability to communicate normally 
could impact social interactions with peers throughout life, 
as well as potentially contributing to aggressive behavior 
[278].  
  Ultrasonic vocalizations (USVs) constitute one major   
method of communication for rodent pups [279,280]. Several  
studies have reported alterations in USV following prenatal  
drug exposure [281-285], although results following PC   
exposure have been mixed [40]. Neonatal exposure to   
cocaine (PND 4-11; 20 mg/kg/day) seems to cause either an  
increase or decrease in isolation-induced USV on PND 14  
[282,283], and PC exposure (GD 7-17; 20 mg/kg/day) has  
been reported to decrease USV in mice [284]. Several recent  
studies have shown alterations in the number, mean duration,  
and spectral characteristics of rodent pup USVs following   
PC exposure (GD 1-20; 30 mg/kg/day) [183,184,286,287].  
These differences may impact the type of maternal care the  
pups receive [287], indirectly impacting the developing   
serotonergic system (see Section D.2. Early Environmental  
Stress Disrupts Serotonergic Signaling Throughout   
Development). 
SSRI Exposure 
  Very little work has been done to investigate differences 
in human communication following prenatal SSRI exposure. 
Infant crying is affected by prenatal exposure to antidepres-
sants, and these effects are known to last up to 2 months after 
birth [33]. However, no differences have been observed in 
language development in 2-5 year old children [221], sug-
gesting that changes in infant communication may be a tran-
sient effect. These data suggest that SERT inhibition may not 
be a critical factor in these issues in PC exposed children.  
7.2. Serotonin Receptor Changes May Explain Early   
Deficits in USVs  
  Preclinical studies can help guide clinical research to 
focus on receptors mediating particular behaviors. Studies 
investigating the role of early changes in 5-HT receptor ex-
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but not 5-HT2A or 5-HT3, receptors are important for separa-
tion–induced USVs in infant rodent pups. Full (8-OH-
DPAT), partial (buspirone), and highly-selective (PRX-00023) 
5-HT1A receptor agonists decrease USVs [180,288,289], 
which is consistent with increased 5-HT1A receptor expres-
sion and decreased USVs observed in PC exposed male 
pups. This suggests that a change in receptor expression may 
be responsible for these effects, although this has not been 
directly tested.  
  These results indicate an important role for 5-HT1A in the 
communicative ability of infants, although whether this re-
ceptor is also important later in development for rodent 
communication is currently unknown. Rodent models of 
vocalized communication have proven useful for understand-
ing social, emotional and stress responding in adults 
[253,290-292]. Future studies could investigate whether pre-
natal drug exposure affects serotonergic regulation of these 
vocalizations in relation to the ability to elicit appropriate 
social interactions (see Section C. 6 on Social Interactions). 
This is of particular interest, since little is known about the 
role of 5-HT in language function in humans, and animal 
models may provide evidence that serotonergic regulation is 
important for the development of communication and social 
skills in humans. If 5-HT does play such a role, then poten-
tial pharmacologic interventions might be developed to treat 
PC exposed children who exhibit communication deficits. 
Such tools may also prove useful in treatment of a wider 
range of childhood disorders involving communication prob-
lems, such as autism spectrum disorders.  
D. PRENATAL DRUG EXPOSURE INTERACTS 
WITH THE EARLY ENVIRONMENT 
  The early home environment for infants and children 
plays a critical role in their physiological and psychological 
development. Parental care is the primary source for envi-
ronmental stimuli in infant life and disruptions and/or re-
moval from parental care is extremely stressful for both hu-
man and rodent infants. Early life stress causes a number of 
behavioral (see Section D.2. Behavioral Effects of Dis-
rupted Early Environment) and serotonergic differences in 
adulthood (see Section D.3. Early Environmental Stress 
Disrupts Serotonergic Signaling Throughout Develop-
ment); however, that early life stress may be caused by drug-
induced deficits in parental care. Typically, parental care is 
studied in the mothers of the species, thus we will specifi-
cally discuss disruptions in maternal behavior (MB).  
1. Maternal Drug Use and Depression Disrupt Maternal-
Infant Interactions 
1.1. Gestational Cocaine Exposure  
  In the human population, PC exposed infants are known 
to have altered maternal-infant interactions, particularly 
since cocaine-abusing mothers are less responsive and more 
likely to show hostility toward their infants [293-297], in-
creasing the likelihood that children of these mothers will 
suffer neglect and be placed in foster care [298-301]. In rats, 
gestational cocaine exposure (chronic or intermittent; 30 
mg/kg/day) consistently leads to disrupted maternal-infant 
interactive behavior [53,260,302-304]. Deficits were ob-
served in crouching (high arched-back nursing), licking/ 
grooming the pups, and retrieving them back to the nest, 
which has been interpreted by some as indicative of a de-
crease in motivation for the dams to care for the pups 
[53,260,302-304]. Additionally, many women who abuse 
drugs during pregnancy will continue to do so during the 
postpartum period, and cocaine during this time is known to 
acutely disrupt maternal behavior in rats [304-307]. Human 
studies suggest that PC exposed infants that are premature or 
have low birth weight are physically unattractive and emit 
disturbing, high-pitched, and arrhythmic cries, leaving them 
more vulnerable to neglect [308-310]. The cues produced by 
rodent offspring are also known to contribute to the type of 
care they receive [260,311-313]. This is consistent with the 
effects of PC exposure in rodents, where pups exhibit fewer 
and shorter USVs with differing spectral characteristics 
[184,284,286,287], and therefore may receive less initial 
response from their dams compared to unexposed pups 
[260,287]. Maternal neglect can cause stress in children and 
rodent offspring, and hence can be interpreted as stressful 
early life environment. 
1.2. Gestational SSRI Exposure 
  Significantly less is understood about how SSRIs affect 
MB directly. SSRIs have been contraindicated during lacta-
tion; however, many women continue their use during this 
time. Although SSRIs are affective in some populations at 
relieving depression and increasing maternal gratification 
(the mother’s appreciation of the motherhood), they did not 
improve maternal-infant interactions at 8 weeks postpartum 
[314]. A single animal study has been performed investigat-
ing the effects of common antidepressants on MB, however; 
it thoroughly examined the dose response to both amnofelic 
acid (AFA), fluoxetine and their combination. AFA is a DAT 
blocker sometimes prescribed as an antidepressant in clinical 
population. When AFA is administered at a low dose (1.25 
mg/kg/day) during pregnancy to rats, decreased nursing but 
enhanced licking behavior were observed; but higher doses 
(2.5 and 5 mg/kg/day) did not have major effects [315]. 
When fluoxetine was administered at 3 different doses, only 
the highest (16 mg/kg/day) affected MB by increasing inves-
tigation time (touching/sniffing behavior), with no effects 
observed on crouching, licking or nestbuilding [315]. When 
given in combination at the highest doses (AFA; 5 mg/kg/ 
day and fluoxetine 16 mg/kg/day), deficits in crouching, 
licking and pup investigation were observed, mimicking 
those observed following cocaine exposure during pregnancy 
[315]. Aripiprizole, am antipsychotic which recently began 
to supplement antidepressant treatment regimens [316], can 
acutely disrupt nestbuilding and enhance nursing while   
leaving retrieval and licking unaffected [317]. 
1.3. Postpartum Depression  
  Although the impact of neonatal exposure to SSRIs is 
still uncertain, it is clear that maternal depression can have 
major negative impacts on maternal-infant interactions in 
humans and animal models. In a rodent model bred for de-
pressive-like behavior on the forced swim test (Flinders-
sensitive line), deficits have been reliably observed in re-
trieval behavior, but only after a stressful intervention; how-
ever, another line also bred for depressive-like behaviors 
(Wistar-Kyoto line) showed increased licking behavior in 
both the normative and stressed conditions compared to a 
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has been shown to result in depressive-like behavior in   
the postpartum period and simultaneously disrupt MB [320]. 
In contrast, women with depressive symptoms in mid-
pregnancy show decreased circulating CRH compared to 
non-depressed controls, but unfortunately this study did not 
compare women on SSRIs [321]. Nonetheless, these data 
support the hypothesis that pregnancy and lactation are peri-
ods with differential hormonal regulation.  
  The studies that have been thus far performed are infor-
mative but point to an area in which little work has been 
done: studying the interaction between maternal depression 
and maternal SSRI use in the postpartum period on maternal-
infant interactions. Although SSRIs do not seem to impair 
maternal behavior directly, infant exposure may impact in-
fant behavior that can feedback to the maternal care re-
ceived. Given the importance of treating depression during 
the postpartum period, and the controversy of using SSRIs as 
treatment, it may be prudent to defer to behavioral therapies. 
Behavioral therapies, including interpersonal psychotherapy, 
support groups and parental coaching, have been shown to 
decrease postpartum depression as well as improve maternal-
infant interactions (see [322], for review). This avenue may 
be preferable in the future, but more work is clearly needed. 
2. Behavioral Effects of Disrupted Early Environment 
  The negative impact of adverse childhood conditions has 
been widely studied (for recent reviews see [323,324]) and 
will not be detailed here, but rather the focus will be on be-
haviors disrupted following PC exposure. Disrupted mater-
nal-infant interactions (or early life stress) associated with 
cocaine use by the mother could be playing a direct role in 
some of the behavioral effects observed in their children, 
including cognitive development, aggressive and social   
interactions, and behavioral stress response [21,133,260, 
263,325].  
2.1. Aggression  
  Early life stress has been shown to clearly increase later 
aggression in animal models and clinical populations [326]. 
PC exposed children raised in foster care or by cocaine-using 
mothers exhibit greater aggression than children in stable 
environments [149,327]. Children of depressed mothers 
show greater externalizing behavior [26]. Goodwin and   
colleagues found that adult male rats reared by mothers   
who were gestationally exposed to cocaine showed greater 
footshock-induced aggression, regardless of their own PC 
exposure [328]. Similarly, female pups reared by cocaine-
exposed dams showed increased maternal aggression as 
adults [21].  
2.2. Social Interactions  
  Infants of cocaine-using mothers show decreased emo-
tional engagement with their mothers at 18 months, a fact 
dependent on the quality of mothering rather than PC expo-
sure [217]. Consistent with this, the caregiving environment 
has been found to be the largest factor in language develop-
ment differences in PC and SSRI exposed children 
[221,277]. The type of mothering received directly relates to 
the type of mothering behavior rodents will themselves ex-
hibit [329]. For example, maternal behavior in rat dams is 
disrupted in females reared by mothers gestationally exposed 
to cocaine [260]. Concaveation, the sensitization of virgin 
female and male rats to infant pups, is also decreased in   
juvenile male and female and adult male rats reared by   
cocaine-exposed mothers [263]. Taken together, these   
studies demonstrate that rearing by a cocaine-exposed 
mother can significantly affect later social interactive   
behaviors, and this effect is enhanced if infants were   
prenatally drug exposed as well.  
2.3. Stress Response  
  Children raised in adverse environments show the great-
est impact of PC exposure, as measured by a blunted CORT 
response to psychological stress [206]. Although little work 
has been done to investigate stress after rearing by a cocaine-
exposed mother, a large body of evidence exists demonstrat-
ing the importance of maternal care in the infant’s develop-
ment of a normal stress response or HPA system (for reviews 
see [325,330,331]. Specifically, rats raised with low levels of 
maternal care show increased startle response and increased 
anxiety in an open field [332], and have increased HPA   
activation [330]. The mothering received also impacts the 
neurohormone oxytocin [260,329], another key modulator of 
the stress response system [333-335]. Children of depressed 
mothers show greater anxiety and depression, regardless of 
prenatal SSRI exposure [189].  
3. Early Environmental Stress Disrupts Serotonergic 
Signaling Throughout Development 
3.1. 5-HT Levels are Decreased 
  The role of 5-HT in the developing stress response cir-
cuitry has been extensively studied in preclinical models. 
Early work showed that separation from dams altered 5-HT, 
5-HIAA, and 5-HT/5-HIAA ratios at ages PND 4, 10 and 16 
[336]. The serotonergic system appears to be very sensitive 
to maternal care, since high levels of maternal care stimu-
lates infant hippocampal 5-HT release, allowing for epige-
netic regulation via acetylation of hippocampal glucocorti-
coid receptors (GR), effectively reducing their expression 
well into adulthood [337]. In contrast, low levels of maternal 
care decrease the amount of 5-HT released during infancy, 
which decreases the activity of Nerve Growth Factor-I 
(NGF-I) and CRE Response binding protein (CREB), DNA 
binding proteins that work to increase GR expression 
[338,339]. The increased stress response observed in off-
spring of neglectful mothers is similar to results observed 
following PC exposure. Therefore, it is possible that low 
levels of stimulated 5-HT release observed in PC exposed 
infants [74], in conjunction with low 5-HT release as a result 
of neglectful parenting, could act synergistically to have an 
even greater impact on GR expression, and hence stress re-
sponsiveness, in these animals. Importantly, animal models 
could be used to test this hypothesis in order to develop pos-
sible pharmacotherapies to restore normal stress responses in 
PC exposed children. Such treatments could include deacety-
lases, which have been shown to reverse maternal neglect-
induced GR expression when given in adulthood (for review 
see [340]).  
3.2. Disrupted Interaction Between SERT and 5-HT1A 
  Although the importance of normal patterns of parental 
care on neurobiological development has been known for 
some time [336], only recently has the interaction of rearing 
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tion. Peer-rearing in infant macaques, which is considered 
highly stressful, is associated with lower SERT activity and 
lower 5-HT levels in adulthood [341,342]. Early life stress 
can also decrease 5-HT1A receptor function in the cortex and 
SERT expression throughout the brain in rats [343,344]. Re-
cently, maternal separation has also been found to decrease 
hindbrain SERT in male, but not female, adult rats [345], 
suggesting that the male serotonergic system may be espe-
cially sensitive to disruptions in the early environment. 
These changes are surely aggravated by neglectful maternal 
care, which can also lower levels of 5-HT and 5-HIAA 
[326,346]. Conversely, increased care received (via experi-
menter handling of the pups) reduces anxiety and social 
avoidance in offspring of 5-HT1A knockout mice. This sug-
gests that enhanced maternal care can mitigate deficits 
caused by a lack of 5-HT1A activity [347]. Maternal depres-
sion can impact the development of the serotonergic system 
in human infants. Infants of women who were depressed 
during pregnancy have lower 5-HIAA and dopamine, but 
higher cortisol as newborn as compared to infants of non-
depressed women [348]. Maternal depression was highly 
correlated with childhood emotional disturbances, especially 
in children with a low-activity polymorphism of SERT 
[349]. 
  Taken together, these data indicate that neglect or early 
life stress result in behavioral and serotonergic signaling 
disruptions similar to those observed following PC exposure 
(see  Section B. 2  Serotonergic Signaling Throughout   
Development), especially low 5-HT levels, SERT activity, 
and disrupted 5-HT1A activity. This is an important consid-
eration for clinical populations, since most children remain 
with their biological parents, such that the early stressful 
environment may act synergistically with prenatal drug ex-
posure to cause even greater disruptions than PC exposure 
alone. Fig. (4) illustrates how the combined effect of PC ex-
posure and the early environment may interact to promote 
increased aggression, but could serve as an example of   
how prenatal exposure and early environment may interact  
to disrupt social behaviors or stress response as well.   
Fortunately, behavioral therapies targeted toward parents, 
and possibly pharmacologic interventions targeted toward 
children, can be implemented early that may be capable of 
minimizing the impact of PC exposure. 
E. INCREASED VULNERABILITY TO EFFECTS OF 
PRENATAL COCAINE EXPOSURE 
1. Sex-Related Vulnerability 
  Interestingly, across the behavioral and neurobiological 
spectrum reviewed here, PC exposed males appear more 
vulnerable than females, although one must consider that 
females generally have not received as much attention as 
males in studies over the years. Differences emerge during 
childhood (postnatal development in rodents) and increase 
throughout adulthood, indicating a developmental trajectory 
influenced by the interaction of PC exposure with androgen 
hormones and male behavior. Despite the fact that adult tes-
tosterone levels are unaffected by PC exposure, cocaine can 
alter testosterone incorporation into the hypothalamus [110], 
potentially causing organizational effects that could impact 
reactivity to changes in the hormonal milieu later in life. In 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). PC exposure results in increased aggression through both serotonergic and non-serotonergic neurobiological changes as indicated by 
the solid lines. Early life stress can also increase aggression through changes in both serotonergic and non-serotonergic signaling components 
as indicated by the dotted lines. If an animal experiences both PC exposure and early life stress, the impact of low SERT, low 5-HT and high 
cortical 5-HT1A may be even greater than either insult alone contributing to a greater behavioral impact as indicated by the thicker arrows.  
It is likely that PC exposure offspring would experience early life stress through parental neglect induced by drug use by the parents as  
indicated by the blue arrows. Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors  Current Neuropharmacology, 2011, Vol. 9, No. 3    501 
addition, 5-HT1A receptor activity during the perinatal period 
is important for development of testosterone sensitivity and 
aggressive behavior in adulthood [111], which could be im-
pacted by reduced expression of 5-HT1A receptors during the 
neonatal period, as has been observed in PC exposed rats 
[50]. 
  Testosterone can inhibit the function and expression of 5-
HT1A receptors [108,109], and androgen-induced increases in 
aggression are inhibited by 5-HT1A receptor agonists [248]. 
Expression of 5-HT1A receptors is reduced by PC exposure, 
which could exacerbate the effects of testosterone and lead to 
a further reduction in receptor function in PC exposed males 
during and after puberty, when testosterone levels increase to 
adult levels. Additionally, changes in 5-HT1A receptors in 
adult males may play an important role in the altered stress 
response and aggression often observed in males, since such 
effects may be exacerbated during puberty related to an in-
teraction with 5-HT and testosterone. This idea could be 
tested by measuring endocrine status in PC exposed males in 
clinical and preclinical studies. Males also seem to be more 
sensitive to the interaction between early SERT function and 
early environmental stress [350,345], suggesting that suscep-
tibility to disruptions in the neonatal period caused by mater-
nal neglect may contribute to the behavioral differences ob-
served in males. 
  Although the effects of PC exposure appear to be greater 
in males, for the most part, females have not been studied 
extensively. Future preclinical studies should include   
females to determine whether this apparent sex-specific   
effect is indeed the case. However, differences between 
males and females in serotonergic signaling must still be 
carefully considered [108].  
2. Genetic Susceptibility to Prenatal Drug Exposure 
  An important consideration in the design of future clini-
cal and preclinical studies is the genetic makeup of the sub-
ject population. Recent studies have shown that genetic vari-
ance in SERT, MAO-A and COMT, impact the effect of 
prenatal SSRI exposure in infants [76,351]. As previously 
mentioned, allelic variance exists in several proteins associ-
ated with serotonergic signaling, the roles of which have 
never been investigated in terms of their impact on the ef-
fects of PC exposure [41,43]. However, allelic variance in 
the 5-HT1A receptor has been linked to drug use and with-
drawal [352], suggesting that mothers who continue to take 
cocaine, regardless of negative consequences, may have a 
genetic susceptibility based on serotonergic signaling that 
they may be passing on to their children. Such allelic   
variance has also been associated with aggression [162,353]. 
SERT polymorphisms with lower functionality, similar to 
what could occur in PC exposed children, have also   
been associated with aggression and ADHD [162,353], and 
males are especially sensitive to early environmental stress 
[162,354], potentially creating a positive feedback loop lead-
ing to poor behavioral outcomes for these children dependent 
on multiple insults to serotonergic function. Future studies 
utilizing animal models deficient in serotonergic signaling 
components would significantly increase understanding of 
the role genetic variation may play in vulnerability to prena-
tal drug exposure.  
CONCLUDING REMARKS 
 Fig.  (5) presents a simplified model of how PC exposure 
induces alterations in embryonic and neonatal serotonergic 
signaling molecules (including low S100, SERT and 5-
HT1A) can result in an overall decrease in 5-HT signaling 
during infancy. This deficit has long lasting effect on adult 5-
HT signaling, as well as HPA activity. Dysregulation of the 
HPA axis and 5-HT signaling combine to alter stress respon-
siveness, which interacts with other behavioral problems that 
stem from serotonergic signaling deficits independent of 
stress responsivity. These behavioral problems are com-
monly comorbid and can increase the severity of one an-
other. This could lead to children with multiple behavioral 
problems that last through adulthood. Fortunately, this model 
points to several molecular targets for potential pharma-
cotherapeutic strategies.  
  Clearly, the effects of PC exposure on behaviors are 
complex and are not due solely to changes in serotonergic 
signaling. The impact of such exposure on the development 
of the dopaminergic system is dose-, age- and sex- depend-
ent, similar to effects on serotonergic signaling [18,355]. 
Little is known about how the noradrenergic system is im-
pacted by PC exposure, which should be considered, since 
 
 
 
 
 
 
 
Fig. (5). Developmental Effects of Serotonin Deficits. PC exposure can cause a variety of serotonergic changes during infancy that culminate 
in low serotonergic tone (Box A.) PC exposure causes deficits in adult 5-HT signaling, which may be developmental compensations for early 
disruptions (Box B). The sum of the 5-HT signaling deficits accrued by adulthood lead to a number of interacting behavioral problems and 
overall poor behavioral outcomes (Box C). 502    Current Neuropharmacology, 2011, Vol. 9, No. 3  Williams et al. 
cocaine also blocks NET, and it has been suggested that NE 
may modulate the effects of prenatal SSRI exposure [119]. 
This is an especially important consideration given the inter-
play between these monoaminergic signaling systems during 
brain development. However, it is clear from the available 
literature that PC exposure has a substantial impact on sero-
tonergic signaling throughout the lifetime of both humans 
and animal models. Such changes appear to be associated 
with many of the observed behavioral deficits resulting from 
prenatal cocaine exposure, which need to be directly tested. 
Possible avenues for such investigation include:  
1)  Determining the role of SERT inhibition in complemen-
tary clinical and preclinical prenatal SSRI studies;  
2) Inclusion of females in all studies of the impact of PC 
exposure and prenatal SSRI exposure on the developing 
serotonergic system and related behaviors;  
3)  In depth investigation of male susceptibility to the detri-
mental effects of PC exposure and prenatal SSRI expo-
sure, including the role played by the male hormonal mi-
lieu; 
4) Further investigation of 5-HT1A receptors in increased 
aggression, depression, attention and social interaction 
deficits seen in human and animal PC exposed offspring, 
with an emphasis on potential pharmacologic interven-
tion;  
5)  Further investigation of the interaction of the early envi-
ronment created by drug-using parents with drug-
exposed infants, which can negatively affect an already 
vulnerable developing nervous system;  
6) Devising and implementing early behavioral interven-
tions with both parents and children that may help reduce 
the impact of this double insult.  
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ABBREVIATIONS 
PC  =  Prenatal cocaine  
GD =  Gestational  day 
PND =  Postnatal  day 
5-HT =  5-hydroxytrytophan  (serotonin) 
SERT =  Serotonin  transporter 
SSRI  =  Selective serotonin reuptake inhibitor 
CNS  =  Central nervous system  
HPLC  =  High-pressure liquid chromatography  
PCA =  p-chloroamphetamine  
CORT  =  Cortisol or corticosterone 
ACTH =  Adrenocorticotropic  hormone 
MAO-A  =  Monoamine oxidase A 
5-HIAA = 5-Hydroxyindoleacetic acid 
CSF =  Cerebrospinal  fluid 
COMT =  c-O-methyltransferase 
ADHD  =  Attention-deficit hyperactivity disorder 
USV  =  Ultrasonic vocalization  
AFA =  Amfonelic  acid 
NE(T) =  Norepinephrine  (transporter) 
DA(T) =  Dopamine  (transporter) 
HPA =  Hypothalamic-pituitary-adrenal 
CRF  =  Corticotrophin releasing factor 
GR =  Glucocorticoid  receptors 
NGF-I  =  Nerve Growth Factor-I 
CREB =  CRE  Response  binding 
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